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SUMMARY 
Glucocorticoids (GCs) are steroid hormones exerting several essential 
functions during embryo development and physiological processes in 
adult life. They bind to their specific receptor, which upon ligand 
binding migrates to the nucleus, dimerizes and binds to specific 
glucocorticoid responsive elements (GREs) on DNA, which regulate in 
a positive or negative (nGREs) way the transcription of target genes. 
Besides, glucocorticoid receptor can indirectly regulate gene 
transcription, by means of protein-protein interactions with other 
transcription factors. 
This thesis is focused on the transcriptional analysis of GCs activity in 
the zebrafish model organism. In the first part of my PhD, we set and 
validated a glucocorticoid responsive zebrafish transgenic line (ia20), 
in which the green fluorescent protein EGFP (Enhanced-GFP) is 
located downstream of nine tandem GRE repeats. Thus, this line 
enables us to follow in vivo GCs transcriptional activity, by means of 
fluorescence observation. Endogenous fluorescence is first 
ubiquitously detectable during somitogenesis, becoming then more 
localized in discrete sites during the first days of development, where 
it persists until adulthood. 
EGFP signal increases in a dose-dependent way in response to 
different DEX concentrations, while gr inactivation through antisense 
morpholino causes a strong fluorescence decrease and the loss of 
DEX responsiveness. 
To validate the ia20 line specificity, we exposed embryos to different 
steroids at the same concentration: we observed a signal increase 
only in response to GCs treatments, while fluorescence was not 
modified by mineralocorticoids, androgens and estrogens treatments. 
Besides, we collected larvae every 2 hours for 28 hours and 
demonstrated that the ia20 line is sensitive to the daily endogenous 
GCs concentration fluctuations due to the circadian rhythm. For all 
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these features, we can consider the ia20 line a potent biosensor to 
analyze GCs activity from a spatio-temporal point of view. 
In the last part of this thesis, we put the ia20 line in grs357 mutant 
background. In these mutants, the transcriptional activity of the 
glucocorticoid receptor mediated by a direct DNA binding is missing 
because of a single amino acid substitution in the DNA binding 
domain. The receptor function not requiring a direct DNA binding is 
maintained in mutants. Indeed, the mutation is not lethal in 
homozygosis. This line was generated in order to characterize the 
possible cross-reactivity among different steroid hormones, since 
glucocorticoid, mineralocorticoid, androgen and progestin receptors 
share the ability to bind GREs (that for this reason are also called 
“Hormone Responsive Elements”, HREs). In the ia20 line in grs357 
background we observed a clear fluorescence decrease and a 
complete loss of GCs responsiveness at 3 dpf (days post fertilization), 
even at high GCs concentrations, suggesting that, at least during 
early development, the ia20 line is able to respond only to GCs. We 
also observed a decrease of endogenous fluorescence intensity at 
later stages, at 21 dpf and in some tissues in adults (but the latter 
result derives from a preliminary experiment).  
Besides, preliminary experiments on adult fish suggest that liver and 
gut only respond to glucocorticoid receptor in the ia20 line, because 
these tissues do not show endogenous fluorescence and do not 
respond to DEX in mutant background. In gonads, instead, and 
although to lesser extent in muscle, we hypothesize that androgens 
and progestins receptors may contribute to GREs-mediated 
transcriptional activity. 
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RIASSUNTO 
I glucocorticoidi sono ormoni steroidei con un ruolo di fondamentale 
importanza durante lo sviluppo embrionale e in molti processi 
fisiologici durante tutta la vita. Svolgono la loro funzione legandosi al 
loro recettore che in risposta al legame migra nel nucleo, dimerizza e 
si lega a specifiche sequenze di DNA responsive ai glucocorticoidi 
(glucocorticoid responsive elements, GREs). In questo modo regolano 
positivamente o negativamente (nGREs) la trascrizione di geni 
bersaglio. Il recettore per i glucocorticoidi può inoltre regolare la 
trascrizione genica in modo indiretto, mediante interazioni proteina-
proteina con altri fattori di trascrizione.  
Questo lavoro di tesi si è focalizzato sull’analisi trascrizionale 
dell’attività dei glucocorticoidi nell’organismo modello zebrafish. 
Durante la prima parte del percorso di dottorato è stata messa a 
punto e validata una linea transgenica di Zebrafish (ia20) responsiva 
ai glucocorticoidi, nella quale la proteina fluorescente EGFP 
(Enhanced-GFP) si trova a valle di nove ripetizioni in tandem della 
sequenza GRE. Mediante l’osservazione della fluorescenza è quindi 
possibile monitorare in vivo l’attività trascrizionale dei glucocorticoidi. 
La fluorescenza endogena inizia ad essere apprezzabile a partire dalla 
somitogenesi ed è inizialmente ubiquitaria, per poi localizzarsi in siti 
discreti nei primi giorni di sviluppo dove rimane rilevabile anche in 
età adulta. In risposta al trattamento con diverse concentrazioni del 
glucocorticoide sintetico desametasone (DEX), il segnale della EGFP 
aumenta in modo dose-dipendente, mentre l’inattivazione del 
trascritto per il gr, ottenuta mediante l’iniezione di un morpholino 
antisenso, provoca una considerevole diminuzione del segnale e la 
mancata risposta al DEX. La specificità della linea è stata validata 
trattando gli embrioni con diversi steroidi alla stessa concentrazione: 
il segnale aumenta solo in risposta ai glucocorticoidi mentre rimane 
invariato nei trattamenti con mineralocorticoidi, androgeni ed 
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estrogeni. Inoltre, un campionamento ogni 2 ore nell’arco di un 
periodo di tempo di 28 ore ha dimostrato che la linea transgenica 
ia20 è sensibile alle variazioni di concentrazione dei glucocorticoidi 
endogeni dovute al ritmo circadiano. Queste caratteristiche rendono 
la linea ia20 un efficace biosensore per analizzare l’attività dei 
glucocorticoidi in vivo dal punto di vista spaziale e temporale. 
Durante l’ultimo periodo di dottorato, la linea ia20 è stata messa in 
background mutante grs357. In questi mutanti, l’attività trascrizionale 
del recettore dei glucocorticoidi legata ad un’interazione diretta con il 
DNA viene persa a causa di una singola sostituzione amminoacidica a 
livello del dominio di legame al DNA. Vengono invece mantenute le 
altre funzioni di controllo della trascrizione del recettore. La linea è 
stata generata con lo scopo di caratterizzare l’eventuale presenza di 
cross-reattività da parte dei diversi ormoni steroidei, in quanto i 
recettori per i glucocorticoidi, mineralocorticoidi, androgeni e 
progestinici condividono la capacità di legarsi ai siti GRE (definiti per 
questo motivo anche “Hormone Responsive Elements”, HREs). Nella 
linea ia20 in background mutante abbiamo osservato una notevole 
riduzione nella fluorescenza endogena ed una totale perdita di 
responsività ai glucocorticoidi anche a concentrazioni elevate su 
embrioni di tre giorni. Questo risultato suggerisce la mancanza di 
cross-reattività fra i diversi ormoni steroidei nei primi giorni di 
sviluppo, e questo a causa della mancata espressione di alti livelli dei 
recettori degli altri ormoni steroidei. Per quanto riguarda gli stadi più 
avanzati, la diminuzione nella fluorescenza endogena nei mutanti è 
stata osservata anche a tre settimane e in alcuni tessuti dell’adulto, 
in un esperimento preliminare che dovrà essere in seguito 
approfondito. Esperimenti preliminari su pesci adulti suggeriscono 
inoltre che la fluorescenza osservata nella linea ia20 su fegato ed 
intestino derivi solo dall’attivazione del recettore dei glucocorticoidi, 
in quanto nel mutante questi tessuti non presentano alcun segnale di 
fluorescenza e non rispondono al trattamento con il DEX. Per quanto 
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riguarda le gonadi, e in misura minore il tessuto muscolare, il segnale 
fluorescente presente negli esemplari mutanti e la mancata risposta 
al DEX, possono essere spiegati dall’attività trascrizionale 
determinata  dai recettori per gli androgeni e i progestinici. 
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1. GLUCOCORTICOIDS 
1.1 Glucocorticoids physiological effects 
Glucocorticoids (GCs) are steroid hormones involved in several 
physiological processes and essential for a proper embryo 
development. They exert a fundamental role in homeostasis 
maintenance and stress response. Endogenous GCs control 
metabolism through carbohydrates and protein breakdown, lipid 
deposition and breakdown regulation. Moreover, they can raise blood 
pressure and inhibit cell growth (Buckingham, 2006). GCs promote 
immune cell apoptosis and regulate inflammatory cytokines 
expression: they suppress the expression of pro-inflammatory 
cytokines like Il-1β, Il-6, Il-8, TNF-α and enhance the expression of 
anti-inflammatory cytokines, such as Il-10; they also impair 
leukocyte migration to the site of inflammation, and disrupt 
endothelium, leukocytes and fibroblasts functions during 
inflammation (De Bosscher et al., 2003). Due to these potent anti-
inflammatory effects, they have been used in the last decades for the 
symptomatic treatment of acute and chronic inflammation, 
autoimmune diseases such as asthma, allergy, sepsis, rheumatoid 
arthritis, ulcerative colitis and multiple sclerosis (Sorrels and 
Sapolsky, 2006; Oakley et al., 2013). Besides, GCs play a cardinal 
role in stress response. Stress occurs when the homeostasis is 
threatened, or perceived to be threatened, by physical or emotional 
factors (stressors), and the stress system acts on several tissues in 
order to cope with the stressful situation (Charmandari et al., 2005; 
Buckingham, 2006; Chrousos, 2009). Physical changes include an 
increase of blood pressure, heart and respiratory rate, 
gluconeogenesis and lipolysis and the inhibition of growth, 
reproduction and immune response. Moreover, the stress response 
brings about some behavioral adaptations, like an increase of 
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cognition and attention and the suppression of appetite (Charmandari 
et al., 2005). 
1.2 Circulating GCs synthesis and regulation 
Cortisol is the predominant endogenous GC in humans and teleosts, 
whereas corticosterone is the main GC in rodents, reptiles, 
amphibians and birds; sheep, pig and dog produce an equal amount 
of cortisol and corticosterone (Buckingham, 2006). GCs are 
synthetized from cholesterol in the zona fasciculata of the adrenal 
cortex in mammals and in the homologous structure, the interrenal 
tissue of the head kidney, in teleosts (Buckingham, 2006; Bury and 
Sturm, 2007). Circulating GCs levels are not constant during day 
time, but their biosynthesis varies according to the circadian rhythm. 
In diurnal species, GCs reach their maximum concentration peak just 
before waking. Then the GCs levels remain high during the day, i.e. 
during activity period, while they reach nadir at the beginning of the 
sleep phase, remaining low during the night (Buckingham et al., 
2006; Chung et al., 2010). 
GCs production is finely regulated by the hypothalamus-pituitary-
adrenal axis (HPA) in mammals, and the hypothalamus-pituitary-
interrenal axis (HPI) in fish, consisting in stimulatory signals 
regulated by a feed-back mechanism. The hypothalamus receives 
and integrates neural and humoral stimuli deriving from the presence 
of stressors or circadian factors, and releases a neuropeptide, the 
corticotropin-releasing-hormone (CRH), also known as corticotropin-
releasing-factor (CRF). In most vertebrates, CRH reaches the 
adenohypophysis through the hypophyseal–portal blood vessels. This 
portal system is lacking in fish, where CRH reaches the 
adenohypophysis carried by nerve fibers of the preoptic region 
(Levavi-Sivan et al., 2009). In both cases, the result is the release 
induction of the adrenocorticotrophic hormone (corticotrophin, ACTH) 
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from the adenohypophysis to the systemic circulation. The target 
tissue of ACTH is the adrenal/interrenal tissue, where it activates 
proteins and induces the expression of genes involved in GCs 
biosynthesis, thus stimulating GCs synthesis and secretion 
(Buckingham, 2006; Nesan and Vijayan, 2013; Nicolaides et al., 
2014). HPA and HPI axis regulation is summarized in Figure 1. 
Fig. 1. Summary of HPA and HPI axis. 
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An unbalance of circulating GCs is pathological in humans: an excess 
of GCs causes Cushing’s syndrome, which main features are 
centripetal obesity, muscle weakness, hyperglycemia, diabetes 
mellitus, immunodeficiency, an impairment in wound healing and a 
delay in growth and development. Addison’s syndrome, instead, is 
characterized by an increase in stress vulnerability and is caused by 
an insufficient GCs amount (Buckingham, 2006). 
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2. GLUCOCORTICOID RECEPTOR 
2.1. The nuclear receptor superfamily  
Nuclear receptors are a superfamily of DNA-binding transcription 
factors exerting a plethora of physiological functions through genomic 
or non-genomic, ligand dependent or non-dependent actions. They 
can act as transcription factors by contributing to gene activation, 
repression or release of gene expression (Germain et al., 2006).  
According to DNA binding and dimerization properties, the members 
of the nuclear receptors superfamily can be divided into four classes: 
steroid receptors, RXR heterodimers, homodimeric orphan receptors 
and monomeric orphan receptors (orphan receptors are so called 
because no specific ligand has been identified yet) (Mangelsdorf et 
al., 1995). They can also be split into two subtypes: type 1 nuclear 
receptors, acting as homodimers upon ligand binding, and type 2 
nuclear receptors, acting as heterodimers. Type 1 receptors include 
the “steroid hormone receptors family” composed by the receptors 
for estrogens (ERα and ß), glucocorticoids (GR), mineralocorticoids 
(MR), progestins (PR) and androgens (AR). Type 2 receptors include 
non-steroid hormone receptors like vitamin D receptor (VDR), thyroid 
hormone receptor (TR), retinoic acid receptor (RARα, ß and γ) and 
peroxisome proliferator-activated receptor (PPAR), that act mainly as 
heterodimers with the retinoic X receptor (RXR) (Mangelsdorf et al., 
1995).  
The human glucocorticoid receptor (GR) was the first nuclear 
receptor protein cloned by Evans and colleagues in 1985 (Hollenberg 
et al., 1985; Germain et al., 2006; Heitzer et al., 2007).  
Nuclear receptors share a common modular structure, in which three 
major domains are highly conserved among vertebrates: a N-
terminal domain (NTD), a DNA binding domain (DBD) and a C-
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terminal ligand binding domain (LBD) (Kumar and Thompson, 2005; 
Germain et al., 2006).  
The N-terminal domain is poorly conserved, except for a ligand-
independent region, AF-1 (activate function-1), which is able to 
autonomously activate transcription by a direct interaction with the 
transcription machinery (Germain et al., 2006; Heitzer et al., 2007). 
The most conserved domain is DBD (DNA binding domain), especially 
a sixty-six residue core containing eight cysteines that tethraedrally 
clusterize two zinc atoms (zinc finger DNA binding motifs), two α-
helices and a COOH extension. The DBDs of glucocorticoid receptor, 
mineralocorticoid receptor, progesterone receptor and androgen 
receptor recognize the same consensus motif on DNA (hormone 
responsive element, HRE), an imperfect palindromic sequence made 
of two inverted repeats of an hexanucleotide, separated by a 3-bp 
spacer (GGTACAnnnTGTTCT) (Germain et al., 2006; Heitzer et al., 
2007; Merkulov and Merkulova, 2009). HREs are normally located 
upstream of nuclear receptors target genes, and are involved in the 
correct positioning of the receptors and the transcriptional complexes 
(Oakley et al., 2013). When referring to the glucocorticoid receptor, 
HREs are also called glucocorticoid responsive elements (GREs). 
Tissue specificity is determined in different ways: 
• expression of the receptors in specific cell types (McKenna and 
O’Malley, 2002);  
• post-translational modification of the receptors by means of cell 
specific kinases that can modulate the receptors activity 
through the phosphorylation of the NTD, the hinge region or 
the LBD (Weigel and Moore, 2007; Oakley and Cidlowski, 
2011);  
• different chromatin accessibility and recruitment of different 
transcriptional co-activators or co-repressors (Heitzer et al., 
2007; Oakley et al., 2013).  
 
Glucocorticoid receptor 
19 
 
The LBD (ligand-binding-domain) is located at the C-terminus and 
contains the ligand binding pocket. The ligand is bound by means of 
hydrophobic residues, and the hormone-specificity is determined by 
the shape of the ligand binding pocket. Besides, in the glucocorticoid 
receptor, in the absence of ligand, LBD interacts with HSP90 (heat 
shock protein 90), that prevents the receptor from binding DNA. 
Upon ligand binding, HSP90 is released, thus allowing receptor 
dimerization and translocation to the nucleus. LBD also contains the 
hormone-dependent AF-2 (activation function-2) domain, which 
interacts with transcriptional co-activators or co-repressors (Germain 
et al., 2006; Heitzer et al., 2007; Oakley et al., 2013). The general 
steroid nuclear receptor structure is summarized in Figure 2.  
Fig. 2. Schematic representation of steroid hormone receptor domains. NTD: N-
terminal domain, containing AF-1 region; DBD: DNA binding domain; H: poorly 
conserved hinge region; LBD: ligand binding domain, also containing AF-2 region. 
Figure from Heitzer et al., 2007. 
2.2. Glucocorticoid receptor gene in zebrafish  
Despite the whole genome duplication that occurred in teleosts 300-
450 million years ago (Volff, 2005), in the zebrafish genome only one 
glucocorticoid receptor gene (gr, nr3c1) is present (Schaaf et al., 
2009). gr is highly conserved between humans and zebrafish. Both 
human and zebrafish glucocorticoid receptor genes are made of nine 
exons: noncoding exon 1, exon 2 encoding for NTD, exons 3 and 4 
encoding for DBD and exons 5-9 encoding for the hinge region and 
LBD. Exon 9 undergoes alternative splicing, thus generating two Gr 
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isoforms, named Gr-α and Gr-β, that differ in the C-terminal 
residues. This alternative splicing has not been found in rodents (Otto 
et al., 1997). The structure of the human and zebrafish genes and 
the splicing variants are shown in Figure 3 (Schaaf et al., 2009). Gr-α 
is responsible for the canonical glucocorticoid signaling, while Gr-β, 
located in the nucleus, is unable to bind glucocorticoids or their 
agonists and acts as a Gr-α dominant-negative inhibitor. The Gr-β 
isoform may be the cause of glucocorticoids resistance (Schaaf et al., 
2009; Oakley et al., 2013). In this thesis, when referring to 
glucocorticoid receptor, only the Gr-α isoform will be considered. 
Fig. 3. Comparison between the structures of human and zebrafish glucocorticoid 
receptor genes and splicing variants. Two isoforms (Gr-α and Gr-β), which differ for 
40 amino acids at the C-terminus, are present in both species. In humans, the two 
forms derive from the alternative splicing of exon 9. In zebrafish, Gr-α contains a 
shorter exon 8 plus exon 9 whereas the specific sequence encoding for Gr-β 
isoform is constituted by a longer exon 8. Figure modified from Schaaf et al., 2009. 
Alternative splicing also produces several less characterized isoforms 
in the human GR (hGR) (summarized in Figure 4) with different 
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effects on GCs signaling (Oakley and Cidlowski, 2011). GR-γ derives 
from the use of an alternative splice donor site between exons 3 and 
4, causing the insertion of an arginine residue in the DBD, between 
the two zinc finger domains. This single amino acid modification 
causes the activation of different target genes with respect to the α 
isoform, while the binding of the ligand is not compromised (Oakley 
and Cidlowski, 2011). GR-A is lacking of the N-terminal part of the 
LBD, due to alternative splicing linking exon 4 to exon 8. In GR-P, 
exons 8 and 9 are missing, so this isoform lacks of the C-terminal 
region of the LBD. These two isoforms are not able to bind hormones 
(Oakley and Cidlowski, 2011). Moreover, GR-α also undergoes 
alternative translation initiation in exon 2, thus generating eight 
additional isoform. Similarly, also GR-β is predicted to generate eight 
alternative isoforms (Kadmiel and Cidlowski, 2013). 
Fig. 4. hGR isoforms, deriving from alternative splicing. Figure from Oakley and 
Cidlowski, 2011. 
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2.3 Glucocorticoid receptor physiology 
2.3.1 Direct gene expression regulation 
In the absence of ligand, glucocorticoid receptor is located in the cell 
cytoplasm as part of a multimeric complex, including Hsp40, Hsp70, 
Hsp90, P23, Fkbp51 and Fkbp52. In this conformation Gr is 
transcriptionally inactive and Hsp90 keeps the hydrophobic ligand 
domain pocket open, in order to allow high-affinity ligand bond 
(Morishima et al., 2001). Cortisol can pass through the plasma 
membrane by simple diffusion, but its bioavailability inside the cell is 
finely regulated by the equilibrium between two enzymes: 11β-
Hydroxysteroid dehydrogenase type 1 that converts inactive 
cortisone to its active form, cortisol, and 11β-Hydroxysteroid 
dehydrogenase type 2 that oxidizes cortisol to inactive cortisone 
(Oakley et al., 2013).  
Upon ligand binding, Gr undergoes a conformational change and the 
multiprotein complex dissociates, thus exposing the Gr nuclear 
localization signals that trigger Gr translocation to the nucleus 
through nuclear pores. After migrating to the nucleus, Gr directly 
binds to DNA on GRE sequences, in the promoter region of target 
genes, where a new conformational change triggers Gr 
homodimerization, for which the 3 basis pair spacer is critical, and 
the recruitment of transcriptional co-activators (Smoak and 
Cidlowski, 2004; Oakley et al., 2013).  
Besides canonical GREs-mediated signaling, Gr can also act as a 
transcriptional repressor when it directly binds to negative GREs 
(nGREs), thus preventing other transcription factors recruitment. As 
GREs, nGREs are imperfect palindromic sequences (CTCC(n)0-
2GGAGA) but, differently from GRE sequences, the variable length of 
the spacer does not trigger receptor dimerization (Schoneveld et al, 
2004; Smoak and Cidlowski, 2004; Oakley et al., 2013). Pro-
opiomelanocortin (POMC), corticotropin-releasing hormone (CRH) and 
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neuronal serotonin receptor are among the genes that are nGREs-
repressed (Revollo and Cidlowski, 2009). 
2.3.2 Crosstalk with other transcription factors 
Gr can indirectly regulate gene expression through protein-protein 
interactions with Nuclear Factor κB (NFκB), Activator Protein-1 (AP-
1), Signal Transduction and Activator of Transcription (STAT) family 
and Sma-MAD (Smad) family transcription factors. 
NFκB is activated by infection products and pro-inflammatory 
cytokines and induces the transcription of genes encoding for other 
pro-inflammatory cytokines and their receptors, such as tumor 
necrosis factor α (TNFα), Il-1β, granulocyte monocyte colony 
stimulating factor (GMCSF) and inflammatory mediators, like 
cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase 
(iNOS). Interestingly, it also represses Gr GREs-mediated 
transcriptional activation. Gr inhibits NFκB by binding to its p65 
subunity, thus impairing transcriptional activation. Several 
mechanisms have been suggested for this Gr-mediated antagonism: 
a physical impairment for NFκB to reach the nucleus, a competition 
for transcriptional co-activators recruitment, or the interference with 
RNA polymerase activation (De Bosscher et al., 2003; Smoak and 
Cidlowski, 2004; Revollo and Cidlowski, 2009). 
Ap-1 is activated by TNF- α and Il-1β and, similarly to NFκB, activates 
the transcription of pro-inflammatory cytokines and tissue-
destructive enzymes, like collagenase. Gr inhibits Ap-1-mediated 
transcriptional activation with mechanisms that are similar to NFκB 
inhibition, after binding to c-Jun subunity on Ap-1 (De Bosscher et 
al., 2003; Smoak and Cidlowski, 2004; Revollo and Cidlowski, 2009). 
The members of the STAT family are indirectly activated by pro-
inflammatory cytokines, by induction of the Janus Kinase (JAK) 
pathway, and regulate genes involved in growth, survival, apoptosis, 
host defense, stress, and differentiation. Gr interacts with several 
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members of the STAT family (STAT-1, STAT-3, STAT-5 and STAT-6). 
Transcriptional regulation can either be positive or negative, 
according to the specific STAT involved, the promoter context and 
external stimuli (Smoak and Cidlowski, 2004; Revollo and Cidlowski, 
2009). Upon Il-6 activation, STAT3 is a potent co-activator of 
glucocorticoid receptor (Zhang et al., 1997). 
Smad family transcription factors are activated by the TGF-β pathway 
that triggers Smad3 phosphorylation, after which Smad3 binds 
Smad4 and they activate the transcription of target genes, involved 
in cell differentiation, extracellular matrix production and immune 
and inflammatory responses. With a still unclear mechanism, Gr 
physically binds the Smad3-4 complex and inhibits its transcriptional 
activation of genes encoding for extracellular matrix proteins and 
protease inhibitors. When phosphorylated, Smad3 can also activate 
Gr-mediated gene transcription (Song et al., 1999; Smoak and 
Cidlowski, 2004; Necela and Cidlowski, 2004; Revollo and Cidlowski, 
2009).  
Figure 5 summarizes the Gr direct and indirect mechanisms of gene 
regulation. 
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Fig. 5. Mechanisms of action of the glucocorticoid receptor. Figure from Smoak and 
Cidlowski, 2004. 
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3. THE GLUCOCORTICOID RECEPTOR IN ZEBRAFISH 
DEVELOPMENT 
3.1. Glucocorticoids in early development 
Many studies in mammals have demonstrated that glucocorticoid 
signaling plays a key role in the development of heart, lungs, gut, 
pancreas, kidneys, bone and brain. Due to external fertilization, 
zebrafish overcomes in utero studies and can be considered more 
suitable than mammals model organisms for the characterization of 
glucocorticoids effects in early development (Nesan and Vijayan, 
2013). Moreover, differently from other teleosts, only one gr gene is 
present in the genome of zebrafish, thus improving gene 
manipulation amenability (Schaaf et al, 2009; Alsop and Vijayan, 
2009). 
The HPI axis is specified within the first day of development and its 
formation is completed by 48 hpf, but no stress response is 
detectable before 72 hpf (Nesan and Vijayan, 2013). Before the 
beginning of de novo cortisol synthesis, only maternal cortisol is 
present in zebrafish eggs. Maternal cortisol shows a 70% decrease at 
25 hpf, and its concentration remains low until the beginning of larval 
cortisol synthesis (Alsop and Vijayan, 2008). The delay in the arising 
of stress response has probably a protective function, to avoid an 
alteration of GCs sensitive pathways in early development (Nesan 
and Vijayan, 2013). Also the glucocorticoid receptor is maternally 
provided in the ovulated egg and its messenger shows a decline 
during the first hours of development, reaching nadir at 8 hpf. 
Maternal transcripts are then replaced by the corresponding 
embryonic RNAs (Pikulkaew et al., 2010; Pikulkaew et al., 2011). The 
spatio-temporal gr expression is shown in Figure 6. 
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Fig. 6. Whole mount in situ hybridization with gr probe on wild type embryos. gr 
mRNA is present in the ovulated egg and its concentration declines until MBT, being 
then replaced by zygotic gr transcripts in later stages. Figure from Pikulkaew et al., 
2011. 
3.2. The role of the glucocorticoid receptor in development: 
effects of gr knock-down 
Most of nowadays knowledge about the essential role that maternal 
glucocorticoids play in early development was provided by gr knock-
down experiments performed with the use of morpholino (see 
chapter 4.3.2). A previous work in our laboratory (Pikulkaew et al., 
2011) demonstrated that the absence of the glucocorticoid receptor 
during the first developmental stages causes severe phenotypes in 
embryos and a mortality increase in the early days of life. Morphant 
embryos displayed a delay in growth and development, a small head, 
reduced eyes and otic vesicles. Besides, they showed pericardial 
oedema, a delay in fin and trunk development and a reduced yolk 
absorption, probably caused by reduced or absent sub-intestinal 
veins. Moreover, in morphants swim bladder inflation did not occur 
and head cartilage formation was compromised. They were not able 
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to swim, and poorly responded to touch stimuli. These embryos also 
displayed a dramatic increase of apoptosis rate, corresponding to an 
increase of caspase8 expression, which is involved in apoptosis 
promotion (Pikulkaew et al., 2011). These results were also 
confirmed by the knockdown experiments performed by Nesan and 
coworkers that suggested a role for glucocorticoids in mesoderm and 
muscle formation. In morphants, they observed an expression 
decrease of genes involved in mesoderm specification, that could 
explain the trunk and somite altered phenotypes (Nesan et al., 
2012). The gr trascriptomics analysis revealed a linkage between gr 
and the BMP family. Particularly, bmp2a, bmp2b and bmp4 
expression is reduced in gr morphants. BMPs are deeply involved in 
development, being implicated in dorso-ventral and mesodermal 
patterning, somitogenesis, myogenesis, organogenesis and 
craniofacial morphogenesis (Nesan et al., 2012; Nesan and Vijayan, 
2013b). Moreover, the expression of genes involved in heart 
development, angiogenesis, connective tissue development, retinal 
development and endocrine signaling components was altered in 
these morphants. These data, put together, might provide an 
explanation to the phenotypes observed in morphants (Nesan and 
Vijayan, 2013b).  
 
3.3. In grs357 mutants, Gr transcriptional activity is disrupted 
During a large-scale screening after ENU mutagenesis (see chapter 
4.2.1), Muto and colleagues identified the grs357 mutants. The 
screening was carried out in order to detect new mutations causing 
alteration of visual behavior (Muto et al., 2005). 
In grs357 mutants, a missense point mutation in gr coding region (Fig. 
7) causes the substitution of an arginine with a cysteine in one of the 
zinc finger motifs in the DNA binding domain. The positive charge of 
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that arginine is essential for DNA binding, hence this mutation 
impairs Gr transcriptional activity, when this is mediated to a direct 
binding to DNA. The hormone binding and the translocation to the 
nucleus are not compromised by the mutation (Ziv et al., 2013). 
Fig. 7. Genotyping of grs357 mutants: a missense single nucleotide substitution (a C 
substituted with a T) causes a single amino acid substitution in zebrafish Gr, that 
impairs DNA binding. 
In mouse, the constitutive knock-out of GR is lethal at embryonic 
stages (Kellendonk et al., 1999), similarly to gr knock-down in 
zebrafish (Pikulkaew et al., 2011). grs357 homozygous mutants, 
instead, do not display morphological phenotypes and are viable until 
adulthood. However, they show a delay in light/dark adaptation 
during larval stage (Muto et al., 2013). Muto and colleagues observed 
that the optokinetic response (OKR) recovery after dark to light 
transition was delayed in homozygous mutants with respect of wild 
type (WT) larvae (30 minutes in grs357-/- larvae vs 5 minutes in WT) 
(Muto et al., 2013). Moreover, grs357 homozygous mutant larvae 
showed an altered visual background adaptation (VBA): the melanine 
granules in the skin are contracted when the larva is exposed to the 
light, while melanine is dispersed in a dark environment. In grs357-/- 
mutants, the VBA adaptation after dark to light transition was 
delayed (Fig. 8) (Muto et al., 2013). gr is widely expressed in the 
retina and Muto and colleagues showed that the expression of several 
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retinal genes, controlled by the glucocorticoid receptor, were altered 
in homozygous grs357 mutants, thus demonstrating that the observed 
phenotype was caused by the disruption of Gr transcriptional activity 
(Muto et al., 2013). 
Fig. 8. VBA delay in grs357-/- 5 dpf larvae (scale bar = 1 mm). Figure from Griffiths 
et al., 2012. 
Ziv and colleagues demonstrated that in homozygous mutants the 
HPA axis is hyper-activated: the concentration of circulating cortisol 
is chronically elevated, but it is not raised by the exposition to 
stressors or the treatment with synthetic glucocorticoids. Moreover, 
they did not display any HPA axis feed-back inhibition in response to 
high concentrations of glucocorticoids (Ziv et al., 2013). Adult grs357 
homozygous mutants, due to HPA hyper-activation, displayed 
exaggerated reactions to anxiogenic environments, resembling 
chronic stress syndrome (Ziv et al., 2013). 
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Moreover, the expression of stress markers (crh, pomc) was 
increased in homozygous mutants (Ziv et al., 2013). Interestingly, 
crh and pomc are negatively regulated by Gr through nGRE 
sequences (Revollo and Cidlowski, 2009), thus suggesting that their 
increased expression is caused by Gr transcriptional disruption 
(Griffiths et al., 2012; Muto et al., 2013). 
The loss of gr transcriptional activity in grs357 mutants was in vitro 
confirmed by Ziv and colleagues in 2013, by means of cell lines that 
do not express the glucocorticoid receptor. These cell lines were co-
transfected with the WT or mutated Gr and a construct containing Gr-
dependent transcriptional activatory or repressive sequences 
upstream of target genes. They observed that, in the mutated Gr, the 
transcriptional activity mediated by GREs, nGREs or the tethering of 
other transcription factors upon Gr DNA binding was largely 
eliminated, even after GCs treatment (Ziv et al., 2013). 
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4. ZEBRAFISH  
4.1. A brief excursus on zebrafish: breeding and development 
Zebrafish, Danio rerio, is a small tropical fishwater teleost. It belongs 
to the Cyprinidae family and its natural habitat is South-East Asia. 
Due to its several advantages, it has been widely used in research in 
the last decades to characterize vertebrate development, genetics, 
physiology and for biomedical, toxicological, behavioral and in vivo 
cell biology studies. 
Zebrafish can be bred in laboratory, under reproducible and not too 
expensive conditions. The mechanisms of sex determination are not 
known to date (Nasiadka and Clark, 2012), but males and females 
usually display a clear sex dimorphism (Fig. 9.) that enables 
researchers to set focused husbandries. Males are streamline-shaped 
and their abdomen region is gold-reddish, while in females the 
abdomen is larger than in males and light-silver colored (Nasiadka 
and Clark, 2012).  
Fig. 9. Adult male (top) and female (bottom) Zebrafish. Figure from 
http://carnivoraforum.com/topic/9774568/1/.  
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Fertilization and development are external and every female can 
produce about 200 eggs per spawn. Embryos transparency in the 
early days of development and their small size (about 1 mm 
diameter/length) make them suitable for microinjection, drug 
treatments and in vivo imaging. Development is very fast when 
compared to other vertebrate model species (e.g. mouse), and it can 
be easily followed in the transparent embryos. In zebrafish, 
gastrulation occurs within 10 hours post fertilization (hpf) and by 24 
hpf the body axes have already been established and neurogenesis 
and primary organogenesis are ongoing. By 5 days post fertilization 
(dpf), organogenesis is complete and embryos have already 
developed into swimming and feeding larvae. Figure 10 shows some 
exemplificative embryos and larvae stages from fertilization (0 hpf) 
to 5 dpf. At 3-4 months they reach sexual maturity, so generation 
time is very short and 3-4 generations can be obtained in one year 
(Kimmel et al., 1995; Dahm and Geisler, 2006; Vacaru et al., 2014). 
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Fig. 10. Living wild type embryos and larvae of relevant stages from 0 hpf to 5 
dpf. Figure from Haffter et al., 1996. 
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4.2. Zebrafish genetics tools: a model organism for human 
disease 
Zebrafish is currently used in research as an animal model for several 
disorders, including muscular dystrophies, neurodegenerative 
disease, cancer, diabetes and cardiovascular disease (Ingham, 2009; 
Tavares and Santos Lopes, 2013).  
4.2.1. Forward genetics 
Forward genetics studies are mainly based on the screening of 
mutants, randomly generated with chemical compounds (N-ethyl-N-
nitrosourea ENU), retroviruses or transposons. These approaches 
were widely used in past years, but they are time-consuming and 
display a great disadvantage: since most of the zebrafish genome 
was duplicated, many genes are redundant and it might not be 
possible to identify the phenotype of each of them (Huang et al., 
2012; Varshney and Burgess, 2013). 
4.2.2. Reverse genetics 
After the sequencing of human genome, with the arising of reverse 
genetics approaches, the zebrafish importance as a model for human 
genetic disorders has been quickly growing. The zebrafish genome 
sequencing has been completed and annotated by the Wellcome 
Trust Sanger Institute. It contains about 26000 protein-coding genes, 
70% of which were identified as human orthologs (Howe et al., 
2013). As reverse genetics approaches in zebrafish, both gene knock-
down and gene knock-out are now possible. In these cases, the issue 
of redundancy can be solved by targeting both paralogs. 
Gene knock-down is based on the microinjection, in one cells 
embryos, of morpholinos (MOs), 18-25 basis long artificial single 
strand oligonucleotides in which the nucleotides backbone is 
chemically modified in order to prevent nuclease-mediated 
Zebrafish 
37 
 
degradation, without disrupting the Watson-Crick base pairing 
between morpholinos and nucleic acids (Eisen and Smith, 2008). 
Antisense morpholinos are used to target specific mRNAs and prevent 
the transcript maturation and translation. The resulting phenotypes 
will be phenocopies of those caused by genomic mutations (Huang et 
al., 2012). 
They can bind to the ATG site, thus blocking maternal and zygotic 
transcripts translation, or to a splice site, thus affecting only zygotic 
transcripts. In this thesis, gr will be silenced both with ATG-
morpholino and splicing-morpholino, previously validated in the 
laboratory (Pikulkaew et al, 2011).  
Morpholino effects do not need to be confirmed by genotyping and 
the knock-down can be performed on many embryos simultaneously. 
However, MO knock-down displays some limits: it undergoes dilution 
at every cell division, thus losing efficiency after 4-5 days, and its 
effects are not heritable (Dahm and Geisler, 2006; Huang et al., 
2012).  
Moreover, several additional controls are necessary in order to 
confirm that the observed phenotype is specific and not caused by 
toxicity: 
• One critical step is the determination of MO effectiveness. If a 
specific antibody is available, the knock-down efficiency can by 
validated by western blot. For MOs targeting splicing sites, the 
effectiveness can be tested simply by PCR (Eisen and Smith, 
2008). 
• To detect the possible effects caused by injection toxicity, a 
mismatch MO, differing from the working MO for five bases, 
should be co-injected in parallel with the active MO. If MO 
effects are specific, the embryos injected with this control MO 
should display no altered phenotypes (Eisen and Smith, 2008). 
• If the phenotype is specific, it should be rescued by co-injection 
of MO with the target gene mRNA (Eisen and Smith, 2008). 
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• 15-20% of MOs, for still unknown mechanisms, activate the 
p53 pathway, causing apoptosis induction and non-specific 
phenotypes. This limit can be overcome by co-injection of a MO 
targeting p53 (Eisen and Smith, 2008; Huang et al., 2012). 
Fig. 11. Schematic representation of different types of MO oligos. Figure from PhD 
thesis of Tatjana Skobo, 2014. 
In recent years, new promising knock-out techniques based on 
engineered DNA-binding proteins were developed, with the great 
advantage of enabling the generation of targeted mutations. TALENs 
mediated gene targeting exploits the transcription activator-like 
effectors (TALEs), DNA-binding proteins naturally produced by a plant 
pathogen bacterium, fused with the catalytic site of an endonuclease, 
FokI (Varshney and Burgess, 2013). CRISPR and Cas system is based 
on the engineering of a host defense system of bacteria and archaea. 
In this technique, a DNA site-specific cleavage is mediated by a 
CRISPR RNA that, when annealed to a trans-activating RNA, guides 
the nuclease cas9 to the target site on DNA, producing a site-specific 
cleavage (Varshney and Burgess, 2013). 
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4.2.3. Transgenesis: the Tol2kit strategy 
Transgenesis has been developing in the last decades as a potent tool 
to characterize in vivo cellular, biochemical and molecular processes 
such as gene expression, signaling pathways and transcriptional 
regulation during development, adult life and disease (Kwan et al., 
2007; Moro et al., 2013). 
Kwan and coworkers elaborated a new strategy (the Tol2kit), based 
on the Gateway system that overcame most of the disadvantages of 
previous transgenesis techniques, which were time-consuming and 
displayed low efficiency (Kwan et al., 2007). In the Gateway cloning 
system, three entry vectors (5’ entry vector, middle entry vector and 
3’ entry vector) are directionally combined in a final destination 
vector by means of the recombination between two specific 
recombination sites (att) located at their extremities, deriving from 
lambda phage. The 5’ entry vector contains the enhancer-promoter 
elements. They can be constitutive promoters (e.g. β-actin2) for 
whole organism expression, conditionally activated promoters (e.g. 
hp70 for heat-shock activation or UAS for Gal4-induced activation) or 
minimal promoters (e.g. thymidine kinase) located downstream of 
transcriptional regulatory elements. The middle entry vector supplies 
the reporter gene, which is usually a fluorophore such as the 
enhanced green fluorescent protein (EGFP) or the monomeric red 
fluorescent protein (mCherry). The 3’ entry vector contains the 
transcription termination signal (PolyA) from SV40. If necessary, it 
can also carry a subcellular localization tag. After joining the three 
entry vectors, they are cloned in a Tol2-based destination vector. The 
destination vector is flanked by Tol2 transposon sequences, which are 
essential for transposition (Kwan et al, 2007; Moro et al, 2013). The 
building of the expression donor construct is represented in Figure 
12. 
Zebrafish 
 
40 
 
Fig. 12. The building of a transgenic expression donor construct: the 5’ entry 
vector (p5E), the middle entry vector (pME) and the 3’ entry vector (p3E) are 
combined together and cloned to a destination vector (pDestTol2pA), flanked by 
Tol2 transposon sequences. Figure modified from Kwan et al., 2007. 
The donor construct is then microinjected in one cell embryos, 
together with the mRNA encoding for a transposase, which is 
translated into protein in the receiving cells. The transposase 
recognizes the Tol2 sequences and catalyzes the excision of the 
donor construct and its integration in the genome. The integration 
becomes stable after transposase degradation. F1 offspring of the 
injected F0 embryos (outcrossed with wild type fish) is then screened 
for reporter detection, to identify the founders in which the construct 
has stably integrated in the germ line (Kawakami, 2007) (Fig. 13). 
This thesis mainly deals with the generation and validation of a 
transgenic line by means of the Tol2kit, in which nine tandem repeats 
of the glucocorticoid responsive elements (GREs), located upstream 
of the thymidine kinase minimal promoter, drive the expression of 
the reporter gene EGFP in order to in vivo detect the GRE-mediated 
transcriptional activity of the glucocorticoid receptor. Results related 
to this transgenic line have been recently published (Benato et al., 
2014). 
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 Fig. 13. Schematic representation of the transgenesis in Zebrafish. Figure from 
Kawakami, 2007.  
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5. MATERIALS AND METHODS 
5.1. Animals maintenance and handling  
Zebrafish (Danio rerio) were raised, staged and maintained according 
to standard protocols (Kimmel et al., 1995; Westerfield, 1995; 
Lawrence, 2007). Eggs are obtained by natural mating and raised up 
to 6 dpf in Petri capsules. Feeding larvae and juvenile fish (from 6 dpf 
to one month post fertilization) are bred in one-liter tanks, while 
adults are transferred to 5-liters tanks with continuous UV-sterilized 
water circulation. 
Larvae are fed starting from 6 dpf with the commercial diet Novotom, 
Premium Baby (JBL, Neuhofen, Germany) twice a day, while juveniles 
and adults are fed twice a day with dry food (AZ300, Tetra) and once 
a day with Artemiae salinae, which are purchased as cysts and 
incubated into saline water for 48 h. Zebrafish are grown and bred at 
their optimum temperature, which is 28.5°C, with a pH range of 7.0-
7.4 and conducibility between 200 and 400 µS, in fish water (50X: 75 
g Instant Ocean; 25 mM Na2HPO4; 25 mM NaH2PO4 in deionized 
water). Fish are kept in a 14 h light/10 h dark light cycle with light 
turning on at 8.00 am and off at 10.00 pm, which is critical for 
experiments concerning glucocorticoids, since their regulation 
depends on the light/dark rhythm. Natural matings are set in the late 
afternoon in suitable tanks where fish are kept separated during all 
night; mating occur in early morning, upon light onset. Eggs are 
collected with a tea net and immediately transferred in Petri dishes 
filled with fish water.  All live animals procedures were approved by 
the institutional ethics committee for animal testing (C.E.A.S.A.). 
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5.2. Imaging 
5.2.1. Microscopy 
For confocal and fluorescence microscopy transgenic embryos, larvae 
and adult tissues were embedded in 0.8% low-melting agarose 
(Sigma-Aldrich) and placed on a Petri capsule filled with fish water or 
on a depression microscope glass. Confocal images were recorded 
with the Nikon C2 confocal system. Fluorescent images were acquired 
with a Leica DFC300 FX digital camera on a Leica MZ16F 
stereomicroscope. 
WMISH-stained embryos were mounted in 87% glycerol in PBT or 
cleared and mounted in 2:1 benzyl benzoate/benzyl alcohol, 
observed under a Leica DMR microscope, and photographed with a 
Leica DC500 digital camera. 
5.2.2. In vivo imaging 
For screening after 48 hpf and in vivo imaging, embryos and larvae 
were anesthetized with 0.04% tricaine (ethyl 3-aminobenzoate 
methanesulfonate salt) (Westerfield, 1995). Screening and in vivo 
imaging were performed with the Leica MZ16F stereomicroscope and 
a Leica DFC300 FX camera. For in vivo imaging, anesthetized larvae 
were embedded in 2% methylcellulose (Sigma-Aldrich) on a 
depression microscope glass. The transgenic line Tg(12xGli-
HSV.Ul23:nlsmCherry)ia10 was used to localize the floor plate cells 
(Corallo et al., 2013).  
5.3. Nucleic acids extraction 
5.3.1. Genomic DNA extraction 
Genomic DNA was extracted by clipped fins or whole embryos with 
DNeasy Blood and Tissue Kit (Qiagen), according to the 
manufacturer’s instructions. Final elution was performed with 100 µl 
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nuclease free water and samples were stored at -20°C until use. For 
tail fin clipping, adult zebrafish were anesthetized with 0.04% tricaine 
and laid on a sterile Petri dish; one third of the fin was clipped with 
surgical scissors an collected in a 1.5 ml microcentrifuge tube,  then 
fish were transferred in a labelled tank and kept isolated to enable 
identification. 
5.3.2. Total RNA extraction 
10-30 embryos or larvae (according to their size) were fixed in 1 ml 
TRIzol Reagent (Invitrogen) in 2 ml microcentrifuge tubes and 
homogenized with glass beads in a Mini-Beadbeater (Biospec 
Products). After homogenization, samples were incubated for 5 
minutes at room temperature (RT) for nucleoprotein dissociation. 
After that, 200 µl chloroform were added and the tubes were 
centrifuged at 13000 g for 15 minutes at +4°C. All the RNA was 
contained in the aqueous supernatant, which was carefully 
transferred in a new 1,5 ml microcentrifuge tube. An equal volume of 
isopropanol was added, and samples were incubated at -20°C for at 
least 3 hours for RNA precipitation. After precipitation, the tubes 
were centrifuged at 13000 g for 15 minutes at +4°C and supernatant 
was eliminated. The resulting pellet was washed twice with 500 µl 
70% ethanol, dried and re-suspended in 10-30 µl nuclease-free 
water. RNA samples were treated with DNAseI (DNA Free RNA kit, 
Zymo Research) to eliminate possible genomic DNA contaminations, 
and stored at -80°C until use.  
5.4. Reverse transcription 
For qPCR, 1 µg of total RNA derived from three different pools of 
embryos at each developmental stage was used for cDNA synthesis, 
with M-MLV Reverse Transcriptase, RNase H Minus, Point Mutant 
(Promega). cDNAs were stored at -20°C until use.  
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5.5. Quantitative polymerase chain reaction (qPCR) 
qPCRs were performed with SYBR green method using a 7500 Real-
Time PCR System (Applied Biosystems, Foster City, CA) and the 
GoTaq®qPCR Master Mix (Promega) following the manufacturer’s 
protocol. We set reaction conditions for each couple of primers (listed 
in Table 1) and selected 56°C as an annealing and elongation 
temperature suitable for all couples. Cycling parameters: 
 
Threshold cycles (Ct) and dissociation curves were generated 
automatically by Applied Biosystems software. Sample Ct values were 
normalized with Ct values from Zebrafish housekeeping gene 
elongation factor-1a (ef1a), which was invariant in treated and 
control embryos at the same developmental stage. All analyses were 
performed in triplicate. The Relative Expression Software Tool 2009 
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(REST 2009) (Pfaffl et al., 2002) was used to estimate relative fold 
changes in the genes of interest, using a ratio of the Ct values and 
the PCR amplification efficiencies of the genes of interest and the 
housekeeping gene. REST 2009 uses randomization and 
bootstrapping methods to test the statistical significance of the gene 
expression ratios and calculate 95% confidence intervals for relative 
fold changes (Pfaffl, 2009). Significance of up-regulation of egfp 
expression with respect to fkpb5 expression in the ia20 line response 
to pharmacological treatment with DEX was analyzed with GraphPad 
Prism Software. Primer sequences are reported in Table 1. 
Primer Sequence 
ef1a-F 5’-GACAAGAGAACCATCGAG-3’ 
ef1a-R 5’-CCTCAAACTCACCGACAC-3’ 
fkbp5-F 5’-GTGTTCGTCCACTACACC-3’ 
fkbp5-R 5’-TCTCCTCACGATCCCACC-3’ 
egfp-F 5’-CCGACCACATGAAGCAGCAC-3’ 
egfp-R 5’-CCAGGATGTTGCCGTCCTC-3’ 
Tab. 1. List and sequences of primers used for qPCR in this thesis 
5.6. Generation of Tg(9xGCRE-HSV.Ul23:EGFP)ia20 reporter 
plasmid 
To prepare the GRE reporter plasmid, we placed in tandem nine 
consensus GREs (TGTACAggaTGTTCT, with uppercase letters 
representing the GRE from the rat tyrosine aminotransferase 
promoter) (Grange et al., 1991). Briefly, we annealed and PCR 
amplified two phosphorylated oligonucleotides (5’-GTA GCT GAA CAT 
CCT GTA CAG GAT GTT CTA GC-3’ and 5’-GTA GCT AGA ACA TCC TGT 
ACA GCT CGA CGT AGC TAG AAC ATC CTG TAC A-3’; consensus GRE 
sequence is underlined), under the following reaction conditions: 
enzyme activation (Iproof High Fidelity PCR kit, Biorad, Milan, Italy) 
at 95°C for 30 s followed by 40 cycles of denaturation (95°C for 30 
seconds), annealing (40°C for 5 seconds) and extension (72°C for 20 
seconds). PCR conditions are here summarized: 
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Reaction products were gel purified (Wizard® SV Gel and PCR Clean-
Up System, Promega, Milan, Italy), ligated to one another using T4 
DNA ligase (Promega) and cloned into pGEM-T Easy plasmid 
(pGEM®-T Easy Vector System, Promega), according to the 
manufacturer’s instructions. Nine GRE tandem repeats were PCR 
amplified (from a positive clone using two specific oligonucleotides 
(pGEM-GRE-F: 5’- CCCAAGCTTGGGTTCGATTGGATG-3’ with HindIII 
restriction site in bold letters and pGEM-GRE-R: 5’-
CCGCTCGAGCGGTAGTGATTTAGC-3’ with XhoI restriction site in 
bold), purified (Wizard® SV Gel and PCR Clean-Up System, 
Promega), digested with HindIII and XhoI (Promega), gel purified, 
and ligated into the HindIII/BamHI sites of the p5E-MCS, a 5’-entry 
vector from the Tol2 kit (Kwan et al., 2007) together with the 
thymidine kinase promoter (tk), retrieved by SalI/BamHI double 
digestion from PCR-blunt II-TOPO-tk (Moro et al., 2009). 
Ligated 9xGRE-tk products were confirmed by sequencing. The 
resulting plasmid (p5E-9xGCRE-HSV.Ul23) was a 5’-entry clone 
suitable for the Gateway system. This clone, along with two Multisite 
Gateway-compatible entry vectors from the Tol2 kit (Kwan et al., 
2007), a middle entry vector carrying the egfp open reading frame 
named pME-EGFP and a 3’-entry vector carrying a SV40 polyA tail 
from pCS2+ (p3E-polyA), were incubated in the presence of the LR 
Clonase II Plus Enzyme mix (Invitrogen) and the destination vector 
pDestTol2pA2 as previously described (Kwan et al., 2007). The 
resulting destination plasmid contained a GRE-dependent EGFP 
reporter construct flanked by the minimal Tol2 transposon elements 
and was named Tg(9xGCRE-HSV.Ul23:EGFP) reporter plasmid. 
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Reporter plasmid DNA (25–50 pg) was co-injected along with 25–50 
pg of in vitro transcribed Tol2 transposase mRNA (Kawakami et al., 
2004) into wild type (WT) 1-cell stage embryos. 
5.7. Drug treatments and microinjection of morpholinos (MOs) 
Zebrafish transgenic embryos were incubated with different 
chemicals, all purchased from Sigma- Aldrich (Milan, Italy): 
• Dexamethasone 
• Cortisol 
• Corticosterone 
• Prednisolone 
• Progesterone 
• 17-β Estradiol 
• 11-Ketotestosterone 
• Aldosterone 
• 11β-deoxycorticosterone (DOC) 
• Mifepristone (RU486) 
All the chemicals were dissolved in 100% ethanol to prepare stock 
solutions. Drug stocks were directly diluted in 25 ml fish water to 
reach the desired final concentrations. Each treatment was performed 
in triplicate with 15 embryos per replica. Controls were incubated 
with an equal volume of 100% ethanol diluted in fish water. 
Morpholino (MO) (Gene Tools, Philomath, OR) treatment was 
performed with grATGMO (MO2-nr3c1), an antisense MO against the 
ATG translation initiation site of gr mRNA, grsplicMO (MO4-nr3c1), a 
splice-site targeting MO as well as grmismMO (MO2-nr3c1-5m), as  
specific control MO, all previously described (Pikulkaew et al., 2011). 
For each MO, 8.2 ng were injected in the yolk of 1-cell stage 
embryos. Injections were performed under a dissecting microscope 
using a microinjector attached to a micromanipulator (Leica 
Microsystems, Milan, Italy). MO-injected embryos were then 
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incubated in 1X fish water at 28.5°C up to the desired stages of 
development.  
5.8. Circadian rhythm dissection 
Analysis of light-dependent modulation of transgene reporter 
expression was performed in 5 dpf ia20 larvae, which were collected 
at 2 h intervals. Collection started from 2 h before light onset (6 
a.m.) and continued for 28 h, until 10 a.m. of the following day. In 
order to avoid exposing accidentally larvae to light during the dark 
period (from 10 p.m. to 6 a.m.) or to stressful stimuli while collecting 
their siblings, larvae were split into 28 single Petri dishes before 
starting collection. For a more detailed analysis close to light onset, 
from 3 hours before light onset (5 a.m.) to 5 hours after light onset 
(1 p.m.), larvae were collected every hour. 
5.9. Whole mount in situ hybridization (WMISH) 
5.9.1. Embryos preparation 
Zebrafish embryos were fixed overnight at +4°C in 4% 
paraformaldehyde (PFA, Sigma Aldrich) in phosphate-buffered saline 
(PBS, Sigma Aldrich) at the required stages of development. When 
necessary, pigmentation was removed by hydrogen peroxide 
treatment according to Thisse and Thisse (2008). Briefly, embryos 
and larvae were incubated in 0,5% KOH and 3% H2O2 (diluted in 
milliQ water) and observed under stereomicroscope until pigments 
bleaching. To stop the reaction, embryos were incubated for 5 
minutes with PBS. After fixation and pigmentation removal, embryos 
were stocked in 100% methanol. 
WMISHs were performed as previously described by Thisse and 
Thisse (2008). Protocol will be described in detail in chapters 5.9.2, 
5.9.3 and 5.9.4. 
Materials and methods 
51 
 
5.9.2. WMISH day 1 
1) Rehydratation 
Embryos stocked in 100% methanol were incubated with decreasing 
methanol concentrations: 
• 75% methanol in PBS (5 min) 
• 50% methanol in PBS (5 min) 
• 25% methanol in PBS (5 min)  
• 100% PBT (PBS + 0,01% Tween20, Sigma Aldrich) (4x5min) 
2) Permeabilization 
From 1 dpf onwards, embryos were digested with 10 µg/ml 
Proteinase K (Promega) in PBT to improve their permeability to 
probes and antibodies. Incubation time depends on the embryos 
stage (15 additional minutes every further day post fertilization). 
To stop the reaction, embryos were incubated with 4% PFA in PBS for 
20 minutes, followed by PBT washing (5x5min). 
3) Hybridization 
Embryos are incubated for at least 2 hours with hybridization mix, 
HM (60% Formamide; 5x SSC; 0.46% pH 6.0 Citric Acid; 50 µg/ml 
Heparin; µg/ml tRNA) at hybridization temperature, which varies 
according to the probe used for hybridization. For all the probes used 
in this thesis (listed in Table 2), hybridization temperature was 65°C. 
Gene Reference Vector Endonuclease, RNA polymerase 
egfp Benato et al., 2014 p3E-EGFPpA ApaI, T7 
fgf8 Reifers et al., 1998 pCRII XhoI, T7 
fkbp5 Benato et al., 2014 pGem ApaI, Sp6 
otx5 Gamse et al., 2002. pBS-IISK+ NotI, T7 
zgr Pikulkaew et al., 2011 pGem ApaI, Sp6 
Table 2. List of riboprobes used for WMISH in this thesis. 
Hybridization mix is then removed and replaced with Hybridization 
mix containing 100 – 200 ng of the probe. Embyos were hybridized 
overnight at 65°C. 
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5.9.3. WMISH day 2 
1) Post-hybridization washes:  
• 100% HM, (very brief wash); 
• 75% HM /25% 2X SSC for 15 min at 65° C 
• 50% HM /50% 2X SSC for 15 min at 65° C 
• 25% HM /75% 2X SSC for 15 min at 65° C 
• 2XSSC for 15 min at 65° C 
• 0.2X SSC for 2X15min at 65° C 
• 75% 0.2X SSC/25% PBT at room temperature (RT) 
• 50% 0.2X SSC/50% PBT at RT 
• 25% 0.2 X SSC/75% PBT at RT 
• 100% PBT at RT 
2) Antibody incubation 
Embryos were pre-incubated for at least 2 hours with PBT containing 
2% sheep serum and 2 mg /ml of BSA. After that, they were 
incubated overnight at 4°C with the antibody, anti-DIG or anti-FLUO 
conjugated with alkaline phosphatase (Roche) diluted 1:3000 in PBT-
2% sheep serum-2 mg /ml of BSA.  
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5.9.4. WMISH day3 
1) Post antibody incubation washes 
 PBT, 6x15 min 
2) Staining 
Prior to staining, embryos were washed three times for 5 minutes 
with staining buffer for NBT-BCIP (100 mM pH 9.5 TrisHCl; 50 mM 
MgCl2; 100 mM NaCl; 0.1% Tween20 [Sigma-Aldrich] diluted in 
milliQ water) or staining buffer for Fast Red (100 pH 8.2mM TrisHCl; 
0.1%Tween20 in milliQ water) in order to reach an alkaline pH. After 
that, they were incubated in staining solution, made of NBT-BCIP 
(Roche) or Fast Red tablets (Roche) diluted in staining buffer. 
Staining was carried out in the dark in 24 well-plates, until proper 
signal intensity was reached. Reaction was stopped through an 
incubation in 4% PFA in PBS, overnight at 4°C. 
3) Embryos preparation for observation: 
• For whole mount imaging, hybridized embryos were incubated 
in 87% glycerol or cleared and mounted in 2:1 benzyl 
benzoate/benzyl alcohol. If necessary, yolk was removed. 
• For vibratome sectioning (Leica VT1000S), embryos were 
embedded in gelatin-albumin (2.2 g gelatin, 135 g BSA, 90 g 
sucrose, 450 ml PBS for 450 ml) in 24 well-plates. 52.5 µl of 
25% gluteraldehyde were added to 750 µl of gelatin-albumin 
and quickly poured in the well; embryos were placed and 
oriented, then another gelatin-albumin-gluteraldehyde layer was 
added for a complete embedding. 
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5.10. grs357 mutants 
5.10.1. Genotyping 
For genotyping, 100 ng of genomic DNA derived from fin clipping or 
single embryos was used for PCR with Biotherm Taq polymerase 
(Società Italiana Chimici, SIC). Primers were designed in order to 
amplify a 205 bp region which includes the grs357 point mutation: 
PCR was performed under strict reaction conditions, in order to 
obtain pure PCR products that did not need to be purified prior to 
sequencing: 
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Sequencing was performed by BMR Genomics (Padova, Italy). For 
sample preparation, 20 ng of PCR product were dried at 65°C with 
3.2 pmol of the forward primer (5’-GTC TCT TGA CAC ATC CTG-3’). 
5.10.2. ia20/grs357-/- line generation 
In order to obtain the ia20 line in grs357 background (Muto et al., 
2005), we crossed ia20 males with homozygous (grs357-/-) females. All 
the resulting progeny was heterozygous and was screened to identify 
fluorescent larvae, which were grown until adulthood. We crossed 
heterozygous (ia20/ grs357+/-) male fish with heterozygous grs357+/- 
females and we grew their fluorescent progeny until adulthood. 
Adults were genotyped through fin clipping in order to identify 
homozygous (ia20/grs357-/-) mutants. Experiments were performed 
with the fluorescent progeny of male ia20/grs357-/- mutants crossed 
with female grs357-/- mutants, which carries the transgene in 
heterozygosity. 
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6. RESULTS 
All the results contained in chapters from 6.1 to 6.7 were published 
in the following research paper: 
Francesca Benato*, Elisa Colletti*, Tatjana Skobo, Enrico Moro, 
Lorenzo Colombo, Francesco Argenton, Luisa Dalla Valle.  
“A living biosensor model to dynamically trace glucocorticoid 
transcriptional activity during development and adult life in 
zebrafish.” 
Mol Cell Endocrinol. 2014 Jul 5; 392(1-2):60-72. 
doi: 10.1016/j.mce.2014.04.015. Epub 2014 May 4. 
*The first and second authors contributed equally to this work. 
6.1. Generation of a GC-responsive transgenic zebrafish line  
The first step to generate a zebrafish model to analyze in vivo the 
GR-mediated GC activity was the building of a transgenic construct 
suitable for microinjection, by means of the Tol2 kit (see chapter 
4.2.3). Thus, we assembled a transgenic construct containing nine 
consensus GREs upstream of a thymidine kinase (tk) minimal 
promoter [Herpes Simplex Virus (HSV) thymidine kinase gene (Ul23)] 
and the egfp coding sequence (Figure 13). The cassette obtained was 
used to generate the destination vector in the Tol2 transposon 
backbone (Kawakami, 2007; see chapter 4.2.3). One-cell stage 
embryos were co-microinjected with the transgenic construct and in 
vitro transcribed Tol2 transposase mRNA.  
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Fig. 13. Schematic representation of the 9xGCRE-HSV.Ul23:EGFP reporter 
construct designed in this study. The construct consists of a 0.45-kb fragment 
encoding nine repeating GREs (in black) from the rat tyrosine aminotransferase 
promoter (Grange et al., 1991) and a thymidine kinase (tk) promoter (HSV.Ul23, in 
dark grey) inserted upstream of the egfp ORF (in green). The SV40 polyA signal 
(SV40pA in grey), which contains a transcriptional termination element, is directly 
downstream of the EGFP ORF and the entire element is flanked by Tol2 
transposable elements. 
6.2. Transgene expression analysis 
When we observed the injected embryos fluorescence, at the 
fluorescence microscope, we initially detected transient EGFP 
expression diffused throughout the embryo by 1 dpf. By 2-3 dpf the 
fluorescent protein became more spatially restricted and localized in 
many tissues such as liver, muscle and intestine. Injected embryos 
where grown until adulthood and outcrossed with wild type (WT) fish, 
in order to identify the transgenic founders, in which the injected 
construct had been integrated in the germ line cells. Six independent 
transgenic F0 chimeric founders were identified and analyzed. We 
crossed them with WT fish, thus generating new stable transgenic 
lines and analyzed the egfp expression pattern in F1 progeny. F1 
embryos from all the founders shared an almost identical EGFP 
expression pattern with differences only in the intensity of the 
fluorescent signal (data not shown), thus suggesting the 
independence of the degree of transgene expression from the 
genomic site of insertion. From these six lines, the one with the 
highest fluorescence intensity was selected and used to perform all 
the experiments described here. This transgenic line was named 
Tg(9xGCRE-HSV.Ul23:EGFP)ia20, (nicknamed ia20). From this point 
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onward, in all the described experiments we used the name ia20 to 
indicate this line. 
Once the ia20 line was stabilized, we characterized in detail the 
transgene expression pattern during development in the F2 
generation, deriving by F1 transgenic fish outcrossed with WT. EGFP 
fluorescence was detectable just after fertilization in the offspring of 
transgenic females mated with WT males (data not shown), while it 
was first visible from early somitogenesis (14 hpf) in the offspring of 
transgenic males crossed with WT females (Fig. 14 A-A’).  
Fig. 14. Fluorescence microscopy (A-D) and light microscopy (A’-D’) lateral views 
of zebrafish embryos and larvae at 14 hpf and 1, 3 and 6 dpf displaying the EGFP 
accumulation sites and the egfp mRNA localization during development. The protein 
and mRNA are first detectable at 14 hpf, when they both are ubiquitously 
distributed, with higher signals in the developing head and tail region (A-A’). The 
EGFP protein/mRNA localization remains the same by 1 dpf (B-B’), while it is visible 
in distinct domains, such as brain, liver and pronephros at 3 dpf (C-C’). By 6 dpf, 
the reporter expression is particularly intense in liver, intestine and pronephros (D-
D’). Scale bar: 200 µM. 
To validate and enhance the results we obtained through the 
observation of fluorescence, we performed RT-PCR essays, that has 
been repeated three times with embryos belonging to independent 
matings, to analyze egfp mRNA expression at 0, 1, 2, 3, 4, 5, 6, 7, 8, 
16 and 24 hpf. Transgene transcripts were already detected at 0 hpf 
in the offspring of transgenic females (Fig. 15B), while they were 
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evidenced by 2 hpf in the offspring of transgenic males (Fig. 15 A). 
The results of fluorescence analysis and RT-PCR, put together, 
suggested that the egfp mRNA was maternally deposited in the ia20 
line, as demonstrated by the presence of egfp mRNA and 
fluorescence (not shown) at 0 hpf, whereas zygotic transcription of 
the transgene, as highlighted in the offspring of transgenic males, 
started by approximately 2 hpf, although levels were very low until 4 
hpf. From this point forward, we always used embryos and larvae 
deriving from the outcross of male ia20 fish with WT females for our 
experiments, in order to avoid every alteration of results caused by 
maternal effect in early development. 
Fig. 15. RT-PCR analysis of egfp expression from the offspring of transgenic male 
(A) or female (B) and wild type mates at stages ranging from 0 up to 24 hpf. 
Expression of ef1a was used as a cDNA loading control. 
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The spatio-temporal endogenous expression of the reporter in the 
ia20 line was thoroughly analyzed during embryonic and early larval 
development by whole mount in situ hybridization (WMISH), 
fluorescence microscopy and confocal laser scanning microscopy.  
Our analysis revealed that, in the absence of exogenous GC 
treatment, egfp mRNA and protein, first detected at 14 hpf, were 
more localized in the developing head, posterior trunk and tail bud 
(Fig. 14 A-A’). This egfp expression pattern is very similar to the gr 
pattern observed at 15 hpf by WMISH in a previous work of this 
laboratory (Pilkukaew et al., 2011; see figure 6 in chapter 3.1). The 
shift in temporal reporter expression detected by RT-PCR, WMISH 
analyses and in vivo fluorescence microscopy was clearly due to the 
different sensitivity of the three techniques and to the time required 
for messenger translation into protein. 
At 1 dpf, fluorescence was still strong in the head and showed an 
ascending gradient along the caudal trunk, with some intensity 
around the yolk sac and its extension (Fig. 14 B). This expression 
pattern was confirmed by WMISH analysis of egfp mRNA (Fig. 14 B’). 
From 3 dpf on, fluorescence intensity in the head and tail regions 
started to decline, to become more localized in the internal organs at 
6 dpf, especially in the abdominal region (Fig. 14 C-C’-D-D’).  
For comparison, we also analyzed the possible presence of non-
specific auto fluorescence (Fig. 16, panel A’-D’) and egfp expression 
(Fig. 16, panel A’’-D’’) in WT embryos at the same developmental 
stages. We did not detect any non-specific egfp mRNA or EGFP 
fluorescence signal, thus confirming that the results of fluorescence 
analysis and WMISH shown in figure 14 represent the actual 
expression of the transgene, i.e. the sites where the glucocorticoid 
receptor is active. 
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Fig. 16. Bright field (A-D), fluorescence microscopy (A’-D’) and egfp WMISH (A’’-
D’’) of wild type zebrafish embryos and larvae at 14 hpf and 1, 3 and 6 dpf 
displaying no transgene signal. Scale bar: 200 µM. 
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For a more exhaustive analysis of the EGFP fluorescence pattern in 
ia20 fish, we performed a thorough confocal analysis on larvae at 2 
and 5 dpf. This additional analysis, shown in Figure 17, enabled us to 
obtain a detailed localization of cells and tissues responding to 
endogenous GCs. At 2 dpf, EGFP signal was detected in known GC-
target organs, such as olfactory bulbs and tracts (Figure 17A), 
pituitary (Figure 17B), liver (Figure 17E), pronephros (Figure 17F) 
and eye lens (not shown). Moreover, fluorescence was also detected 
in novel tissue domains, such as in the anterior and posterior cristae 
and, more feebly, in the lateral canals of the otic vesicles (Figure 
17C), in mesenchymal-like cells of the skin (Figure 17H) and, in the 
trunk, in two rows of cells located above the notochord (Figure 17G). 
At 2 dpf, EGFP was also detected in the pectoral fin bud epidermis 
(Figure 17D), where it co-localized with fgf8a mRNA (double WMISH 
shown in Figure 18B). By 5 dpf, the reporter was still expressed in 
the above mentioned structures as well as in the heart (Figure 17J), 
pancreas (Figure 17K) and intestine (Figure 17L).  
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Fig. 17. Reporter expression in untreated 2 dpf and 5 dpf transgenic zebrafish 
(transgenic males crossed with WT females). Top panel: schematic representation 
of a 2 dpf embryo indicating the EGFP positive cells and tissues. Below: 20x 
confocal microscopy pictures showing EGFP in olfactory bulbs and tracts (A, dorsal 
view), pituitary (B, dorsal view), otic vesicle (C, lateral view), pectoral fin (D, 
dorsal view), liver (E, lateral view), pronephros (F, lateral view), putative KA’’ cells 
(G, lateral view) and dermal mesenchymal-like cells (H, lateral view). Bottom 
panel: schematic representation of a 5-dpf larva indicating the newly detectable 
EGFP-positive districts in addition to those already revealed at 2 dpf. Below: 20x 
confocal images showing fluorescence in the olfactory bulbs (I, dorsal view), heart 
(J, lateral view), pancreas (K, lateral view) and gut (L, lateral view). Scale bar: 200 
µM. 
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A detailed analysis of the two rows of cells located above the 
notochord revealed that their density was not uniform along the 
antero-posterior axis, but decreased going towards the posterior 
(Figure 17G). To identify their localization with respect to the floor 
plate cells, we crossed ia20 fish with the Tg(12xGli-
HSVTK:nlsmCherry)ia10 line (Corallo et al., 2013), a stable 
transgenic line which display mCherry fluorescent protein expression 
in the floor plate cells, thus generating double transgenic embryos. At 
2 dpf, their localization is mostly lateral with respect to the floor plate 
cells of the ia10 line (Figure 18D). For their expression domain, we 
speculated that these cells might possibly be Kolmer-Agduhr” (KA’’) 
interneurons (Huang et al., 2012). 
Fig. 18. A) Transgene expression (red) colocalizes, at 3 dpf, with otx5 transcripts 
(blu) in the pineal gland as shown by double WMISH (see chapter 6.3). B) 
Transgene expression (red) colocalizes, at 2 dpf, with fgf8 transcripts (blue) in the 
fin as shown by WMISH. C) Lateral section of egfp WMISH at 2 dpf showing 
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putative KA’’ interneurons. D) Transgene expression (green) colocalizes at 2 dpf 
with shh-reporter (red) expression in few KA’’ cells close to the floor plate as shown 
by confocal analysis of double transgenic embryos [Tg(9xGCRE-
HSV.Ul23:EGFP)ia20 X Tg(12xGli-HSV.Ul23:nlsmCherry)ia10]. 
We then performed a WMISH to compare gr spatio-temporal 
expression and transgene activity at the same stages reported in 
Figures 15 and 17. Notably, we here show that the gr messenger is 
expressed in the same area showing transgene activity (Fig. 18). 
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Fig. 19. WMISH of gr transcripts performed at the same stages as figures 15 and 
17. A-D) Light microscopy lateral views of zebrafish embryos and larvae at 14 hpf 
(A), 1 dpf (B), 3 dpf (C) and 6 dpf (D) displaying gr mRNA localization during 
development. E-I) Details of gr positive structures of 2 dpf (F-I) an 5 dpf (E) larvae 
embryos analysed by WMISH. Scale bar: 200 µM. 
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6.3. The ia20 line responds to pharmacological treatment with 
GCs  
Our next goal was the demonstration of the transgenic line 
responsiveness to exogenous GCs, in order to further validate the 
ia20 transgenic line and assess its power as new tool. Thus, we 
outcrossed transgenic ia20 males with WT females and we treated 
their fluorescent progeny with nine different concentrations of the 
synthetic GC dexamethasone, DEX (10, 50, 100, 250 nM, 1, 2.5, 5, 
10 and 25 µM) for 24 h, from 48 hpf to 72 hpf. We observed that the 
larvae treated with 100 nM concentration of DEX or more, displayed, 
in vivo, a fluorescence intensification when compared to vehicle-
treated controls. In larvae treated with higher DEX concentration this 
expression increase became more evident, thus suggesting a dose-
dependent response. Saturation was reached at 10 and 25 µM. This 
dose-response effect was also confirmed by WMISH (Fig. 20). 
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Fig. 20. DEX-induced fluorescence in Tg(9xGCRE-HSV.Ul23:EGFP)ia20 zebrafish 
line is dose-dependent. EGFP protein (on the left) and mRNA (on the right) 
distribution after treatment of transgenics with 10, 50, 100, 250 nM and 1, 2.5, 5, 
10 and 25 µM DEX for 24 h. Treated embryos display a dose-dependent increase as 
compared to their ethanol vehicle-treated siblings. Scale bar: 200 µM. 
Results 
 
70 
 
To verify whether the transgene was responding to the treatment 
with the GC agonist in a dose-dependent manner similar to that of an 
endogenous gene, qPCR analysis was carried out for egfp and fkbp5 
transcripts. fkbp5 is a ubiquitous gene belonging to the family of 
immunophilins. It is part of the multimeric complex that binds the 
glucocorticoid receptor in the absence of ligand (see chapter 2.3.1). 
fkbp5 expression is enhanced by Gr and regulates negatively Gr 
activity, thus forming a negative feed-back loop (Jääskeläinen et al., 
2011). As Jääskeläinen and colleagues demonstrated that fkbp5 is a 
sensitive biomarker of in vivo responses to GCs (Jääskeläinen et al., 
2011), we selected this gene as an endogenous biomarker of GCs 
response in our experiments.  
After 24h DEX treatment, both egfp and fkbp5 expression are 
significantly increased in ia20 larvae. In Figure 21, where the control 
expression value is set at 1, the comparison among the expression 
levels at different DEX concentrations shows that for both genes this 
expression increase is dose-dependent. Transcripts were significantly 
higher after DEX treatment, starting from 1 µM for egfp and 2.5 µM 
for fkbp5. Moreover, egfp was significantly more expressed with 
respect to fkbp5 in larvae treated with DEX at 1 µM upwards. 
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Fig. 21. Fold changes in gene expression of fkbp5 and egfp, in 10, 50, 100, 250 
nM and 1 µM (upper panel) and 2.5, 5, 10 and 25 µM (lower panel) DEX-treated 
transgenics compared to controls (set at 1) with vehicle only. The expression levels 
of the target genes were normalized on ef1a as housekeeping gene. The 
experiment was repeated three times with 10 embryos for each treatment. Values 
represent the mean ± S.E. Asterisks indicate that expression levels are significantly 
different from the control: **P<0.01, ***P < 0.001.  
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A more detailed analysis of the DEX-dependent responsiveness at the 
10 µM concentration in the transgenic line was performed by confocal 
microscopy. A strong fluorescence enhancement with respect to 
control was detected in many tissues such as the pectoral fin 
epithelium (Fig. 22, A-A’), mesenchymal-like cells of the skin (Fig. 
22, B-B’), skeletal muscle fibers (Fig. 22, C-C’), KA’’ interneuron cells 
(Fig. 22, D-D’), as well as in the pituitary (Fig. 22, E-E’ and 
arrowhead in G’). Moreover, EGFP signal also appeared in novel sites 
like blood cells (Fig. 22, arrows panel D’) and in the vessel 
endothelium (Fig. 22, arrows in panel B’). Notably, in these cell 
types, the transgene was not expressed in the absence of GC agonist 
treatment. Moreover, with at least 10 µM DEX, a clear signal 
appeared also in the pineal gland (Fig. 22, F-F’ and arrow in panel 
G’). This localization was confirmed by double WMISH of egfp and 
otx5, a specific marker of the pineal gland (see figure 18, chapter 
5.3.1).  
Results 
73 
 
Fig. 22. Fluorescence increase after DEX treatment and visualization of new 
responding districts. Confocal microscopy (A-F and A’-F’) and fluorescence 
microscopy (G-G’) images of a Tg(9xGCRE-HSV.Ul23:EGFP)ia20 larva treated with 
10 µM DEX compared to control. DEX incubation caused a strong EGFP increase in 
pectoral fins (A’, lateral view), dermal mesenchymal-like cells (B’, lateral view), 
muscle fibers (C’, lateral view), pituitary (arrowhead in E’ and in G’, dorsal view) in 
blood cells and vessels (arrows in B’ and in D’, lateral view) and in the pineal gland 
(arrow in F’ and in G’). Scale bar: 200 µM. 
6.4. Selective response of the ia20 line to different steroids 
As different steroid receptors share the same HREs (see chapter 2.1), 
there might be a possible crosstalk among their pathways, causing a 
non-specific GCs responsiveness. For this reason, a screening was 
carried out to evaluate the responsiveness, during the first 
developmental stages, of the ia20 transgenic line to different 
glucocorticoids (cortisol, corticosterone, prednisolone, 
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dexamethasone), mineralocorticoids (11-deoxycorticosterone, 
aldosterone), progestins (progesterone), androgens (11-
ketotestosterone) and estrogens (17β-estradiol). All steroid 
treatments were performed at the same concentration (5 µM) and 
started at 10 hpf. The effects on reporter expression were evaluated 
by WMISH at 1, 2 (not shown) and 3 dpf and by fluorescence 
microscopy analysis (Fig. 23). Incubation with cortisol led to the 
same results obtained with DEX: a sharp increase of egfp mRNA was 
already visible at 2 dpf in the same tissues. A modest effect on 
reporter activity was detected with corticosterone. The incubation 
with progesterone and prednisolone led to a clear increase of reporter 
transcription. Progesterone responsiveness is probably not due to Gr 
and Pr crosstalk, but to the conversion of progesterone to cortisol. As 
demonstrated by Parajes and colleagues, at 3 dpf cyp11a2, a key 
enzyme in cortisol biosynthesis, is already active (Parajes et al., 
2013). Instead, embryos treated with 11β-deoxycorticosterone 
(DOC), aldosterone, 11-ketotestosterone as well as 17β-estradiol 
displayed expression levels comparable to controls (Fig. 23). Thus, 
until this stage, the ia20 line selectively responds to glucocorticoids, 
as no response to mineral corticoids, androgens and estrogens was 
detected. 
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Fig. 23. Transgenic line responses to different steroid treatments. A) Light 
microscopy dorsal view and B) fluorescence microscopy images of 3-dpf transgenic 
zebrafish treated for 48 h with the indicated compounds at the same concentration 
(5 µM). Responses were visualized both by WMISH of egfp mRNA and in vivo by 
EGFP fluorescence. Cortisol, dexamethasone, prednisolone, progesterone and 
corticosterone treatments increased reporter activity compared to control, while no 
changes were detectable with 11β-deoxycorticosterone (DOC), aldosterone, 11-
ketotestosterone and 17β-estradiol (E2). Threshold areas, highlighted in red and 
corresponding to egfp positive regions, are shown in small boxes on the bottom-
right of single images in each WMISH picture. Threshold was set at 201. . Scale 
bar: 200 µM.  
Dose-dependent responsiveness of the transgenic line to five 
different concentrations (10 nM, 100 nM, 1 µM, 5 µM and 25 µM) of 
cortisol, corticosterone and prednisolone were analyzed by qPCR of 
egfp and fkbp5 transcripts. As reported in Figure 24 and in 
agreement with the WMISH results, the highest reporter induction 
was obtained with cortisol (Fig. 24A), followed by prednisolone 
(Fig.24B) and corticosterone (Fig. 24C). Moreover, the transgenic line 
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appeared sensitive to low doses of prednisolone, as the 
corresponding egfp increase was statistically significant at 100 nM 
and 1 µM for fkbp5 (Fig. 24B). Cortisol produced a significant egfp 
expression increase starting from 1 µM, while fkbp5 was significantly 
augmented from 5 µM. Finally, the ia20 line was less sensitive to 
corticosterone, as both genes reached significance at 5 µM. 
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Fig. 24. Fold changes in gene expression of fkbp5 and egfp, in 10 and 100 nM, 1, 5 
and 25 µM cortisol (upper panel), prednisolone (intermediate panel) and 
corticosterone (bottom panel) treated transgenics compared to controls (set at 1) 
with vehicle only. The expression levels of the target genes were normalized on 
ef1a as housekeeping gene. Values represent the mean ± S.E. Asterisks indicate 
that expression levels are significantly different from the control: *P <0.05, 
**P<0.01, ***P < 0.001. 
6.5. Reporter activity in ia20 fish decreases by GR knockdown 
and RU486 treatment 
For a further validation of transgene expression specificity, we 
knocked-down gr by morpholino microinjection (see chapter 4.2.2) in 
ia20 embryos. One-cell stage embryos were microinjected with three 
different MOs: grATG1MO (MO2-nr3c1) to block the translation of both 
maternal and zygotic gr transcripts; grsplicMO (MO4-nr3c1), a splicing 
MO to block post-transcriptionally the zygotic gr transcripts alone and 
grmismMO (MO2-nr3c1-5m), as a mismatched control MO. The efficacy 
of grATG1MO in targeting and blocking protein translation was 
determined in a previous work using an in vitro 
transcription/translation coupled system, whereas the effectiveness 
of grsplicMO was analyzed by RT-PCR in the same work (Pikulkaew et 
al., 2011). 
We performed a detailed confocal microscopy analysis in grATG1MOs, 
displaying a completely abolished or strongly reduced fluorescence of 
transgenic fish in the target tissues for glucocorticoids previously 
shown in Figure 16 (Fig. 25). Similarly, grsplicMOs analysis revealed a 
consistent or complete fluorescence reduction, while in control 
grmismMOs fluorescence intensity was not altered with respect to non-
microinjected controls (data not shown). 
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Fig. 25. Reporter expression in untreated 2- and 5-dpf transgenic zebrafish 
following gr MOs injections. Top panel: schematic representation of a 2-dpf embryo 
indicating the EGFP positive cells and tissues, as reported in Fig. 2. Below: 20x 
confocal microscopy pictures showing EGFP fluorescence reduction in olfactory 
bulbs and tracts (A, dorsal view, A’, bright field), pituitary (B, dorsal view, B’, 
bright field), otic vesicle (C, lateral view, C’, bright field), pectoral fin (D, dorsal 
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view, D’, bright field), liver (E, lateral view, E’, bright field), pronephros (F, lateral 
view, E’, bright field), putative KA’’ interneurons (G, lateral view, G’, bright field) 
and dermal mesenchymal-like cells (H, lateral view, H’, bright field). Bottom panel: 
schematic representation of a 5-dpf larva indicating the newly detectable EGFP-
positive districts in addition to those already revealed at 2 dpf in transgenic 
zebrafish, as reported in Fig. 2. Below: 20x confocal images showing EGFP 
fluorescence reduction in the olfactory bulbs (I, dorsal view, I’, bright field), heart 
(J, lateral view, J’, bright field), pancreas (K, lateral view, K’, bright field) and gut 
(L, lateral view, L’, bright field). Scale bar: 200 µM. 
To detect GCs responsiveness, morphants and controls were 
incubated with or without 10 mM DEX for 24 h (from 2 to 3 dpf). As 
shown in Figure 26, no EGFP signal enhancement was detected after 
DEX treatment in both ATG and splicing morphants while in 
grmismMOs DEX responsiveness was not altered with respect to non-
microinjected control. 
Fig. 26. Reduced GRE activity following gr MOs injections alone or combined with 
10 µM DEX treatment of 2-dpf transgenics for 24 h. EGFP protein localization in 
controls (ia20 embryos) and after translation-blocking MO (grATG1MO), missplicing 
MO (grsplicMO) and mismatched control MO (grmismMO) injections alone (on the left) 
or combined with DEX treatment (on the right). Scale bar: 200 µM. 
Results 
81 
 
Moreover, grmismMO microinjection did not modify either egfp or 
fkbp5 transcription levels, as assessed by qPCR (Fig. 27) confirming 
the presence of an active Gr. Instead, microinjections with either 
grATG1MO or grsplicMO significantly reduced GC signaling as indicated 
by strong decrease of fluorescence and significant reduction of basal 
fkbp5 gene expression. DEX treatment of the gr-morphants caused 
an increase of the fkbp5 transcripts, suggesting incomplete 
penetrance of the two MOs. Analogously, the egfp transcripts were 
also increased by DEX treatment and this increase was statistically 
significant with respect to control (transgenic ia20 zebrafish without 
DEX) in grsplicMO injected embryos (Fig. 27).  
Moreover, increase of both egfp and fkbp5 transcripts after DEX 
treatment was statistically significant compared to gr-morphants.  
Fig. 27. Fold changes in gene expression of fkbp5 (top panel) and egfp (bottom 
panel) in embryos injected with grmismMO, grATG1MO and grsplicMO w/wo DEX 
treatment as compared to non- injected/non-treated control (set at 1). The 
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expression levels of the target genes were normalized on ef1α as housekeeping 
gene. Values represent the mean ± S.E. Asterisks indicate expression levels that 
are significantly different from control (ia20 embryos) or between samples as 
indicated by the horizontal line: **P < 0.01; ***P < 0.001. 
The specificity of transgene expression was further confirmed by 
treatment of embryos with DEX (10 µM) alone or together with the 
GR antagonist RU486 (50 nM, 250 nM and 1250 nM) for 24 h (from 2 
to 3 dpf). Co-treatment with RU486 caused a significant and dose-
dependent decrease of egfp and fkbp5 mRNA levels compared to 
those in embryos treated with DEX alone (Fig. 28), in agreement to 
the blocking of DEX responsiveness observed by Weger and 
colleagues in the GRIZLY assay (Weger et al., 2012). 
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Fig. 28. Reduced GRE activity following treatment with the Gr antagonist RU486. 
Two-dpf transgenic embryos were treated for 24 h with 10 µM DEX alone or 
combined with three different RU486 concentrations (50, 250 and 1250 nM). Left 
panel: fold changes in gene expression of fkbp5 and egfp in treated embryos as 
compared to only DEX-treated control (set at 1). The expression levels of the target 
genes were normalized on ef1α as housekeeping gene. Values represent the mean 
± S.E. Asterisks indicate expression levels that are significantly different from 
control (DEX-treated ia20): *P<0.05; **P < 0.01; ***P < 0.001. Right panel: 
WMISH of egfp mRNA after DEX treatment alone or combined with RU486 at 
different concentrations. 
Moreover, when morphants were treated with 5 µM progesterone for 
24 h (from 2 dpf to 3 dpf), they did not display any fluorescence 
increase (Fig. 29). The increase was instead seen in control fish. 
Therefore, we validated he hypothesis that the progesterone effect 
was dependent on the metabolic conversion of progesterone to 
cortisol as previously suggested in chapter 6.4. We also 
demonstrated that a functional GR receptor is needed for the 
hormone-dependent induction of transgene activation. 
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Fig. 29. Reduced GRE activity following gr MOs injections alone or combined with 5 
µM progesterone treatment of 2 dpf transgenics for 24 h. EGFP fluorescence and 
messenger WMISH localization after translation-blocking MO (grATG1MO), missplicing 
MO (grsplicMO) and mismatched control MO (grmismMO) injections alone (on the left) 
or combined with progesterone treatment. Scale bar: 200 µM.  
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6.6. Adult fish of the ia20 line show endogenous GR 
transcriptional activity 
After analysing transgene expression at embryonic and larval stages, 
we characterized its persistence and GCs responsiveness during adult 
life (Fig. 30). 
Interestingly, in the ia20 line endogenous fluorescence is still 
detectable during adult life. In untreated adult males and females, 
transgene fluorescence was observed in many tissues, such as the 
esophageal sacs mucosa (Fig. 30A, 30K), ventricular epicardium (Fig. 
30B, 30L), liver (Fig. 30C, 30M), intestinal mucosa (Fig. 30D, 30N), 
testis (Fig. 30E) and ovary (Fig. 30O). A lower fluorescence signal 
was also detected in the brain, skeletal muscle and kidney (not 
shown). In order to analyse the capability of the adult ia20 fish, male 
and female, to respond to exogenous GCs we decided to perform a 
24h treatment with 10 µM DEX. After the treatment, both male and 
female transgenic fish showed an increase of the fluorescence in the 
brain, liver, intestinal mucosa and kidney (not shown) as well as 
detectable transgene expression in the skeletal elements of the 
splanchnocranium (Fig. 30 H’, R’), spinal cord (Fig. 30 J’, T’), eye 
(Fig. 30 F’, G’, P’, Q’) and skin (Fig. 30 I’, S’). 
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Fig. 30. 20x confocal microscopy pictures showing EGFP in control and 10 µM DEX-
treated adult zebrafish males and females: esophageal sacs (A, K), ventricular 
epicardium (B, L; v = ventricle; a = atrium), liver (C, M), intestinal mucosa (D, N), 
testis (E), ovary (O), eye (F-G, F’-G’; P-Q, P’-Q’), skeletal elements of the 
splanchnocranium (H’, R’), skin (I, I’, S, S’) and spinal cord (J, J’, T, T’). Scale 
bars: 200 µM. 
6.7. Transgene expression shows variations in tissues 
specificity and intensity with respect to the light cycle  
The endogenous circulating GCs are not constant during the day, but 
their amount fluctuates according to the light/dark (LD) rhythm (see 
chapter 1.2). In order to evaluate the sensitivity of the ia20 
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transgenic line to the circadian variations of the concentration of 
endogenous GCs, we analyzed egfp transcription by WMISH in 5 dpf 
transgenic larvae exposed to standard photoperiodic regimen (14 h 
light/10 h dark) at 15 time points. Larvae were collected at 2 h 
intervals starting from 2 h before light onset (8 am) for 28 h. 
The analysis of the fluorescence revealed that during the dark period, 
reporter activity was low and mainly limited to the digestive tract 
(from 20 pm to 6 am), but it increased just before the light onset (8 
am), especially in the liver and intestine, where it remained high till 
12 am to decrease later on (Fig. 31A). In the eye and brain, the 
signal increased from 10 to 12 am, and then decreased. The pattern 
observed in 5 dpf larvae was repeated in their 6 dpf siblings collected 
at 6 am, 8 am and 10 am the following day, thus denoting that the 
messenger variations are due to GCs circadian fluctuation and not to 
the different developmental stage. 
For a more detailed analysis of egfp expression close to light onset, 
we also collected 5 dpf larvae once an hour from 3 hours before light 
onset (5 am) to 5 hours post light onset (1 pm) and performed egfp 
WMISH, shown in Figure 32 B. The egfp and fkbp5 messenger 
expression pattern were studied by means of real time PCR of both 
transcripts at 5, 8 and 11 am. This assay showed a significant up-
regulation of both transcripts at 8 am (Fig. 32). Moreover, the same 
expression pattern observed for egfp was obtained by WMISH also for 
fkbp5 expression in wild-type fish (Fig. 31C). Fluorescence analysis of 
transgenic fish showed a similar circadian modulation of transgene 
expression with an EGFP signal delay consistent with the time 
required for translation (Fig. 31A). The decrease of fluorescence was 
slower with respect to the mRNA decrease due to the higher protein 
stability. Finally, WMISH of gr expression (Fig. 31D) did not show 
substantial variations as also reported by Dickmeis and colleagues, 
who did not detect any significant variation of gr mRNA during the LD 
cycle (Dickmeis et al., 2007). This result confirms the hypothesis that 
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the observed variations of egfp and fkbp5 mRNA and of EGFP 
fluorescence depend on the oscillation of GCs concentration, thus 
validating the ia20 line sensitivity to endogenous GCs fluctuations 
during day time. 
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Fig. 31. A) Fluorescence microscopy lateral view, B) WMISH of egfp mRNA of 5 dpf 
transgenic larvae and C) WMISH of fkpb5 mRNA, D) WMISH of gr mRNA of 5 dpf 
WT larvae exposed to standard photoperiodic regime and analysed from 2 h before 
light onset for 28 h. 
Fig. 32. A) fold changes in gene expression of fkbp5 and egfp in 5-dpf larvae 
exposed to standard photoperiodic regime and analysed at 5, 8 and 11 am. 
Expression levels at 8 and 11 am were compared to those at 5 am (set at 1). The 
expression levels of the target genes were normalized on ef1a as housekeeping 
gene. Values represent the mean ± S.E. Asterisks indicate expression levels that 
are significantly different: **P < 0.01; ***P < 0.001. B) egfp WMISH performed on 
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5 dpf larvae collected every hour from 3 hours prior to light onset (5 am) to 5 
hours after light onset (1 pm). Scale bar: 200 µM. 
6.8. Generation and expression analysis of a ia20 line in grs357 
background 
The glucocorticoid receptor shares, with other members of the steroid 
hormone receptors family, (including mineralocorticoid, progesterone 
and androgens receptors), the ability to bind to the same response 
element: the glucocorticoid responsive elements (GREs). For this 
reasons these responsive elements are also called “hormone 
responsive elements” (HREs) (see chapter 2.1). In our previous work 
(Benato et al., 2014), we excluded the presence of significant cross-
reactivity until 3 dpf (see chapter 6.4), but we did not characterize its 
possible occurrence at later stages, when progestogens, androgens 
and mineralocorticoids receptors expression could reach higher 
levels. For this reason, in order to characterize the steroid response 
and possible cross-reactivity through binding to HREs, we generated 
a zebrafish glucocorticoid responsive line (ia20 line; Benato et al., 
2014) in grs357 background, in which Gr transcriptional activity is 
disrupted (Muto et al., 2005; Ziv et al., 2013; see chapter 3.3).  
A detailed confocal microscopy (Fig. 33) analysis of 2 and 5 dpf 
larvae, heterozygous or homozygous for the s357 mutation, revealed 
a clear decrease of the endogenous fluorescence in homozygous 
mutants (ia20/grs357-/-), as expected by the very low occurrence of 
steroid hormone receptors except for Gr. The fluorescence signal was 
very low or absent, with respect to ia20 zebrafish, in some discrete 
sites such as otic vesicle (Fig. 33, A, A’, A”), pectoral fin (Fig. 33, B, 
B’, B”) and putative KA” interneurons (Fig. 33, C, C’, C”) in 2 dpf 
embryos or dermal mesenchymal cells (Fig. 33, H, H’, H”) in 5 dpf 
larvae. In olfactory bulbs (Fig. 33, D, D’, D”), liver (Fig. 33, E, E’, E”), 
gut (Fig. 32, F, F’ F”) and muscle (Fig. 33 G, G’, G”) of 5 dpf larvae 
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the decrease was consistent although a lower fluorescence signal is 
still present.  
A slight fluorescence decrease was detectable in heterozygous larvae 
(ia20/grs357+/-) when compared to WT (ia20/grs357+/+), but this was 
much less remarkable than the decrease observed in ia20/grs357+/-. 
Fig. 33. Confocal images of otic vesicle (A, A’, A”), pectoral fin (B, B’, B”) and 
putative KA” interneurons (C, C’, C”) in 2 dpf embryos (upper panel) and olfactory 
bulbs (D, D’, D”), liver (E, E’, E”), gut (F, F’ F”), muscle (G, G’, G”) and dermal 
mesenchymal cells (H, H’, H”) in 5 dpf larvae (bottom panel) of WT (ia20/grs357+/+), 
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heterozygous (ia20/grs357 +/-) and homozygous (ia20/grs357-/-). Homozygous grs357 
mutants (ia20/grs357-/-) display a less intense endogenous fluorescence with respect 
to heterozygous (ia20/grs357 +/-) and wild type (ia20/grs357 +/+) fish. Heterozygous 
larvae seem to display an intermediate phenotype between WT and homozygous 
fish. 
6.9 Steroid responsiveness to glucocorticoids is lacking in 
grs357 homozygous mutants 
In order to characterize the steroid responsiveness of grs357 
homozygous mutants at early stages, we repeated the 5 µM steroid 
treatments described in chapter 6.4, from 10 hpf to 3 dpf. The results 
obtained show that, differently from wild type fish, 3 dpf grs357 
homozygous mutants lost almost entirely their steroid responsiveness 
(Fig. 34). 
Fig. 34. Fluorescence images of the head region of 3 dpf grs357-/- larvae treated 
with 5 µM steroids from 10 hpf until 3 dpf. For comparison, the fluorescence images 
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relative to the same treatment performed on ia20 embryos in WT background are 
also reported (Benato et al., 2014; see Fig. 22). Wild type larvae (ia20/grs357+/+) 
display a cortisol, dexamethasone, corticosterone and progesterone response, 
whereas ia20/grs357-/- mutants do not show any GCs response. 
Moreover, we performed a 10 µM DEX treatment for 24 h (from 48 
hpf to 72 hpf) on ia20 and ia20/grs357 heterozygous and homozygous 
larvae. As previously demonstrated in vitro by Ziv and colleagues 
(Ziv et al., 2013), we here show in vivo that grs375-/- mutants do not 
respond to DEX (Fig. 35). 
Fig. 35. Embryos were treated with 10 µM dexamethasone from 48 hpf and 
observed at 72 dpf. Dexamethasone response was completely lost in ia20/grs357 -/- 
mutants. A) Fluorescence images of whole 3 dpf larvae. B) Confocal magnification 
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of muscle (A, A’, A”, a, a’, a”), liver (B, B’, B”, b, b’, b”), dermal mesenchymal cells 
(C, C’, C”, c, c’, c”) and pectoral fin (D, D’, D”, d, d’, d”) of 3 dpf larvae. 
6.10. Characterization of ia20/grs357 endogenous EGFP signal 
at later stages 
In our previous work (Benato et al., 2014), we demonstrated that in 
the ia20 line fluorescence is not limited to early development, but it 
persists in later stages (see chapter 6.6 and Fig. 30). In order to 
characterize the specificity of EGFP signal, we compared the 
fluorescence of ia20/grs357+/+ (WT) and ia20/grs357-/- in discrete sites 
at late larval stages (21 dpf): lower jaw (Fig. 36 A, A’), pectoral fin 
(Fig. 36 B, B’), pronephros (Fig. 36 C, C’), liver and skeletal elements 
of the splanchnocranium (Fig. 36 D, D’), muscle and gut (Fig. 36 E, 
E’). As shown in Figure 36, homozygous mutants display a sharp 
fluorescence reduction or elimination in all the districts we took into 
consideration in our analysis. 
Fig. 36. Confocal analysis of lower jaw (A, A’), pectoral fin (B, B’), pronephros (C, 
C’), liver (l) and skeletal elements of the splanchnocranium (s) (D, D’), muscle and 
gut (g) (36 E, E’) showing a strong fluorescence decrease in homozygous mutants 
when compared to ia20 larvae. 
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6.11. Adult grs357-/- fish do not respond to exogenous 
glucocorticoids 
In order to characterize the adult zebrafish glucocorticoids 
responsiveness in the absence of Gr transcriptional activity, we 
performed a DEX treatment (5 µM for 24 h) on male and female adult 
ia20/grs357+/+ (WT) and ia20/grs357-/-. Previous treatments (see Fig. 
34 and 35, chapter 6.9) were performed during early development, 
when the other steroid receptors are expressed at very low levels.  
We analyzed through confocal microscopy four representative sites 
(gut, ovary/testis, muscle and liver), revealing that DEX 
responsiveness is lost in most sites in homozygous mutants, as 
shown in Figure 37: gut (female: Fig. 37 A, A’, A’’, A’’’; male: Fig. 37 
B, B’, B’’, B’’’) and liver (female: Fig. 37 G, G’, G’’, G’’’; male: Fig. 37 
H, H’, H’’, H’’’). In muscle (female: Fig. 37 E, E’, E’’, E’’’; male: Fig. 
37  F, F’, F’’, F’’’), we detected a fluorescence decrease in 
homozygous mutants, with remaining signal mostly concentrated in 
the lateral region. Moreover, fluorescence seems to be more intense 
in males. As androgen receptor is known to be expressed in muscle 
at a lower rate in females with respect to males (Hossain et al., 
2008) and no DEX response was observed, this result suggests that 
muscle is also responding to androgens.  Conversely, we did not 
observe any fluorescence differences between ia20/grs357+/+ and 
ia20/grs357-/- fish in gonads, indicating that these structures are likely 
responding to endogenous steroids by means of progesterone and 
androgen receptors (Fig. 37 D, D’, D’’, D’’’) and (Fig. 37 C, C’, C’’, 
C’’’).  
This was only a preliminary experiment performed in order to have 
an indication of glucocorticoids responsiveness in adult homozygous 
mutants. We will now need to perform further treatments with 
androgens, progesterone and mineralocorticoids in order to finely 
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characterize the cross-reactivity of different steroid receptors in the 
absence of Gr transcriptional activity. 
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Fig. 37. Adult male and female ia20/grs357+/+ (WT) and ia20/grs357-/- (homozygous 
mutants) were treated with 5 µM DEX for 24 h. We observed no DEX response in 
homozygous mutant in gut (female: Fig. 37 A, A’, A’’, A’’’; male: Fig. 37 B, B’, B’’, 
B’’’) and liver (female: Fig. 37 G, G’, G’’, G’’’; male: Fig. 37 H, H’, H’’, H’’’). No 
appreciable differences were observed between ia20/grs357+/+ and ia20/grs357-/- in 
gonads (ovary: Fig. 37 C, C’, C’’, C’’’; testis: Fig. 37 D, D’, D’’, D’’’). In muscle 
(female: Fig. 37 E, E’, E’’, E’’’; male: Fig. 37 F, F’, F’’, F’’’), fluorescence decreases 
in ia20/grs357-/- mutants, where it is concentrated in the lateral region. 
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7. DISCUSSION 
Most of this PhD thesis is dealing with the setting, description and 
validation of a transgenic zebrafish line, “ia20”, in which the 
activation of the GCs signaling pathway can be monitored in vivo. The 
transcriptional activity of the glucocorticoid receptor can be 
thoroughly analyzed not only from a spatial point of view, but it can 
also be followed during development and adult life. The integrated 
reporter transgene incorporates a conserved GRE tandem repeat that 
has been multiplied nine-fold to increase cooperative binding of 
ligand-activated Gr to GRE and boost transcription initiation of the 
egfp transgene (Jantzen et al., 1987). The egfp transgene is located 
downstream of these nine GRE repeats, which drive and strongly 
activate its transcription. As a result, a massive EGFP production 
occurs in all the cells where the glucocorticoid receptor is activated. 
One current issue in the generation of transgenic lines is positional 
effect, i.e. a different transgene expression pattern according to the 
genomic contest in which the transgene has been inserted. As 
recommended by Fisher and colleagues, we analyzed the offspring 
generated by several independent founders (Fisher et al., 2006). 
They showed the same EGFP expression pattern, thus ruling out 
positional effects.  
The transgenic line exhibits a high sensitivity, as evidenced by the 
detection of regionalized fluorescence in embryonic head and tail 
driven by endogenous GCs already at 14 hpf. Recently, Weger and 
colleagues set an in vivo GCs responsive line where four GRE repeats 
drive the expression of luciferase (Glucocorticoid Responsive In vivo 
Zebrafish Luciferase Activity, GRIZLY, assay) (Weger et al., 2012; 
Weger et al., 2013). In the GRIZLY assay, response was 
demonstrated to start at 1 dpf and only under DEX stimulation. This 
line represents an effective tool for GREs-mediated chemical 
screenings, but does not enable a detailed spatial analysis of GCs 
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activity. The ia20 line, instead, allowed us to have a thorough 
dissection of the spatio-temporal GCs activity in vivo (see results in 
chapter 6.2). The use of a fluorescent molecule as reporter provides 
a higher spatial resolution, as shown by clear EGFP signaling in 
isolated dermal mesenchymal-like cells, blood and two rows of cells 
located above the notochord, possibly corresponding to the KA’’ 
interneurons. These cells are distributed irregularly along the lateral 
floor plate domain and, after differentiation, lose the ability to 
respond to the Hedgehog (Hh) signal (Huang et al., 2012). This could 
explain the lack of total co-localization between GRE and Hh activity 
in the cells when we outcrossed the ia20 line with a floor plate 
reporter (see chapter 6.2). 
The human glucocorticoid receptor expression has been finely 
described by Pujols and colleagues and the overall expression pattern 
of our zebrafish transgenic line is extended to all sites of potential 
GCs activity (Pujols et al., 2002). Steroid selectivity of the reporter 
demonstrated high responsiveness to cortisol, DEX and prednisolone, 
low responsiveness to corticosterone, and ineffectiveness of 
mineralocorticoids, androgens and estrogens. The low corticosterone 
responsiveness is not surprising as the physiologically most relevant 
glucocorticoid in teleosts is cortisol, and corticosterone activity as an 
agonist is weaker with respect to cortisol and dexamethasone (Stolte 
et al., 2008). 
The intense GRE-driven transcription induced by progesterone may 
be partly ascribed to its greater high cellular permeability as 
compared to GCs and to the conversion of progesterone into cortisol.  
In fact the steroidogenic enzymes involved are already active in 
larvae, as demonstrated by a 90% reduction of cortisol 
concentrations in morphants of cyp11a2, at 72 hpf with respect to 
controls (Parajes et al., 2013). Moreover, progesterone 
responsiveness could also reflect some affinity of this steroid for GR, 
as reported in dog (Selman et al., 1996) and humans, where it acts 
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as a low potency agonist (Koubovec et al., 2005). Interference by 
binding of progesterone to its specific receptor (Pr) is unlikely 
because pr mRNA levels are very low till 2 dpf in zebrafish (Pikulkaew 
et al., 2010). The hypothesis that the strong progesterone response 
might be caused by binding of the Pr to the reporter transgene was 
also excluded by incubating the gr-morphants (grATG1MO and 
grsplicMO) with 5 µM progesterone (see Fig. 29). While in control fish 
the hormone treatment induced an increase of transgene activity, in 
gr-morphants we did not detect evident effects. Therefore, we 
validated the hypothesis that the progesterone effect was dependent 
on Gr and, thus, on the metabolic conversion of progesterone to 
cortisol. Consequently, we can assume that, at least until 3 dpf, the 
ia20 line steroid responsiveness is selectively restricted to 
glucocorticoids.  This conclusion is also supported by the clear and 
strong reduction of GCs responsiveness observed at 3 dpf in the 
ia20/grs357-/- line, where the transcriptional activity of Gr is disrupted 
by a single amino acid substitution affecting DNA binding that impairs 
both transactivation and trans-repression (Ziv et al., 2013; see 
chapter 3.3). Our data, put together, suggest that, at least until 3 
dpf, the ia20 transgenic line is only reporting GCs activity. 
In the ia20 line, dose-dependent responsiveness to DEX was 
established after exposure to increasing DEX concentrations, 
concomitantly with enhanced expression of egfp and fkbp5 mRNAs. 
Similarly, signaling driven by endogenous GCs in target organs was 
strongly magnified by exogenous DEX. Although the activity of GCs in 
vivo was normally enhanced using micromolar concentrations of DEX, 
as also reported for the GRE-Luc line (Weger et al., 2012), in the 
ia20 line the egfp mRNA increase, analyzed by qPCR, was statistically 
significant already at 1 µM. However, differences in the fluorescence 
levels and the hybridization signals were already appreciated at 100 
nM of DEX. Similarly, signaling driven by endogenous GCs was highly 
amplified by adding DEX and the ia20 line has been found to respond 
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in a dose-dependent manner also to GCs agonists such as cortisol, 
prednisolone and corticosterone. 
Knockdown of maternal and/or zygotic gr mRNAs determined a 
strong reduction of reporter activity induced by DEX and curtailed 
expressions of egfp and fkbp5 mRNAs. The fact that these mRNAs 
were more reduced in morphant larvae not exposed to DEX suggests 
that DEX over-induced reporter activity, largely compensating for the 
knockdown effect. A similar decrease of fluorescence was obtained by 
co-treatment of transgenic embryos with the GR antagonist RU486 
suggesting that, at early stages, the fish line is only reporting GC 
activity. 
The similar modulation of egfp and fkbp5 expression under different 
treatments is remarkable, because it demonstrates that, despite its 
artificial assemblage, the transgene is operating like an endogenous 
promoter. This matching, however, is only partial, because it does 
not cover indirect transactivation and transrepression due to 
crosstalk between GR and other transcription factors, given the 
absence of additional docking sites for them in the transgene 
promoter (Kassel and Herrlich, 2007). 
From a quantitative point of view, the increased number of 
responsive elements with respect to the ones located upstream to the 
fkbp5 gene makes the transgene more prone to cooperativity and 
transcription, and the increased sensitivity enables the detection of 
new GC responsive targets, as the cristae and lateral canals of the 
otic vesicles, and scattered mesenchymal-like cells and putative KA’’ 
cells.  
Notably, we first detected an ascending rostro-caudal gradient of 
transgene, with the highest levels of GRE-reporter activity in the 
caudal portion of 24-hpf larvae. This expression pattern could be 
related to the key action of Gr signaling in axial mesoderm 
development, which is disrupted when gr expression is perturbed 
(Wang  et al., 1999; Nesan et al., 2012).  
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Interestingly, similarly to the well-known morphogen retinoic acid, 
also GCs play a function in modulating Wnt antagonists, in particular 
during differentiation of mesenchymal stem cells (Beildeck et al., 
2010). Moreover, mouse skeletal development and mesenchymal 
progenitor cells are committed to osteoblastic lineage via a GC-
dependent Wnt signaling (Zhou et al., 2009). 
Relevant is our finding of localized transgene expression in the 
cardiac district of 2-dpf embryos and in the heart of 5-dpf larvae as 
well as in adult fish, where it is particularly intense in the ventricular 
epicardium. In mice, GC signaling is required for fetal heart 
maturation (Rog-Zielinska et al., 2013) and its over-activation 
through GR conditional expression perturbs adult cardiac physiology 
through conduction defects (Sainte-Marie et al., 2007). Given the 
persistence of transgene expression in the adult zebrafish heart, it is 
plausible that also in teleosts GC signaling plays a critical role in 
cardiomyocyte function and remodelling after insults, as shown in 
mice (De et al., 2011; Ren et al., 2012). We also found that the 
esophageal sacs mucosa expressed, particularly at adulthood, a high 
level of reporter transgene. A key role of GCs signaling in promoting 
cell proliferation and apoptosis in the esophageal epithelium was 
already demonstrated in medaka (Takagi et al., 2011). Moreover, 
adrenalectomy has been reported to result in reduced cell 
proliferation in the rat small intestine (Foligne et al., 2001). 
Pleiotropic effects of GCs have been proposed in the small intestine 
where, at least in mouse and human, an autonomous synthesis of 
these steroids has been recently documented (Mueller et al., 2007). 
In this organ, GCs are involved not only in the regulation of locally 
confined immune responses (Mueller et al., 2007), but also in 
intestinal cell maturation and transcriptional activation of genes 
involved in the absorptive function (Quaroni et al., 1999). Thus, it 
may be envisaged an involvement of GCs in tissue renewal and 
support of digestive function in the esophageal sacs and intestinal 
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tract. DEX treatment in adult ia20/grs357-/- seems to confirm the GCs 
specificity of the EGFP signal in the digestive system observed in the 
ia20 line. Indeed, liver and gut displayed a consistent decrease of 
endogenous fluorescence and a loss of DEX responsiveness in the 
absence of Gr transcriptional activity, suggesting that, in these adult 
tissues, the transgenic line is only reporting GCs activity. However, 
this was only a preliminary experiment and further treatments with 
progesterone, androgens and mineralocorticoids will be necessary in 
order to confirm this result. 
The expression of the transgene in adult muscle and its DEX 
responsiveness suggest that this tissue responds to GCs, but the 
incomplete fluorescence elimination in ia20/grs357-/- mutants indicates 
that muscle is likely responding also to androgens. Moreover, in 
agreement with our findings, it was previously demonstrated by 
Hossain and colleagues that the androgen receptor is expressed in 
zebrafish muscle at a higher rate in males than females (Hossain et 
al., 2008). 
Fluorescence was observed also in the ovary of ia20 transgenic 
females. Confocal analysis of this organ demonstrated localized EGFP 
expression in follicular cells and in the ooplasmic and nuclear regions 
of developing oocytes. A modulation of ovarian functions by GCs as 
well as the presence of their receptor have been demonstrated in 
human, where it limits inflammation and tissue injury during 
ovulation (Rae et al., 2004), rat (Tetsuka et al., 1999) and teleost, 
with a possible role in the diversion of energy resources from ovarian 
growth to other tissues during chronic stressful situations (Leatherlan 
et al., 2010).  Actually, fluorescence showed by ovulated oocytes and 
RT-PCR detection of maternal egfp mRNA starting from one-cell stage 
suggest the possibility of a continual activation of the GC signaling 
pathway throughout female gametogenesis. On the other hand, pr 
transcripts and proteins have been found at high concentrations in 
zebrafish ovaries, both in follicular cells and early-stage oocytes 
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(Hanna et al., 2010). Since the GRE sequence is shared as 
responsive element by the progesterone-Pr complex, an involvement 
of the latter in transgene ovarian activation cannot be excluded. 
Similarly, given GRE responsiveness also to Ar, transgene activation 
in the testis of adult zebrafish could be related to androgen receptor 
present in Sertoli cells contacting spermatogonia (de Waal et al., 
2008) as well as to the occurrence of Pr in Leydig and Sertoli cells 
(Chen et al., 2010). In fact, when we treated with DEX adult ia20 and 
ia20/grs357-/-, we did not observe any appreciable difference between 
wild type and mutant background in these tissues, thus suggesting 
that the EGFP signal did not result from the glucocorticoid activity 
alone and that Pr in ovary and Pr and Ar in testis might bind to GREs 
and contribute to transgene expression. Further treatments with 
progesterone and androgens will enable us to shed light on the 
contribution of these steroids in the GREs-mediated transcriptional 
activation in gonads. 
Albeit only gr mRNA is present at high concentrations in ovulated 
eggs and during early developmental stages (Pikulkaew et al., 2010), 
thus validating the relevance of GC transgene activation in 
embryogenesis, this does not hold at adulthood, when all steroid 
hormone pathways are operative. In order to rule out potential 
modulation of the reporter by other steroid hormones in adult stage, 
specific mutant lines for the different GRE-sharing steroid receptors 
should be adopted. As preliminary DEX treatments of gr mutant line 
suggest that Gr is not the only receptor interacting with GREs in 
gonads, our next goal will be the characterization of Pr and Ar 
contribution in the GREs-mediated transcriptional regulation, by 
means of progesterone and androgens treatments in ia20 and 
ia20/grs357-/-adults. 
The paternally acquired transgene was transcribed in the progeny 
already at 2 hpf, which is strikingly precocious, being timed at the 
cleavage stage, when the synchronous divisions of the blastomeres 
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every 14-15 min limit the window for zygotic transcription (Tadros 
and Lipshitz, 2009). The embryonic content of egfp mRNA increased 
at 3 hpf with mid-blastula transition and remained high from 4 hpf 
onwards. The very early activation of the transgene promoter points 
to a fundamental developmental role of GCs and their receptor in 
zebrafish ontogenesis, as previously speculated (Pikulkaew et al., 
2011; see chapter 3.2). However, this observation is in contrast with 
the viability of the mutant zebrafish strain, grs357-/- (Ziv et al., 2013). 
The R443C mutant Gr protein of this line can bind cortisol but cannot 
perform DNA binding activity due to a missense mutation located in 
the DNA-binding domain (Ziv et al., 2013) that impairs both 
transactivation and trans-repression. Although morpholino off-target 
effects have been excluded by co-injection of p53-MO, we cannot rule 
out that some developmental defects as well as the reduced viability 
of the gr-morphants could be partially ascribed to this problem. In 
mouse a complete inactivation of the glucocorticoid receptor has 
been demonstrated to be inconsistent with life as GRnull/null mice show 
severe abnormalities and die just after birth (Cole et al., 1995). In 
contrast, mice carrying the GRdim/dim (Reichardt et al., 1998), that 
impairs homodimerization and DNA binding of the receptor (A458T), 
are viable. In these mutants the GRE-dependent gene transcription is 
absent whereas other DNA-binding independent activities of the GR 
receptor, such as cross-talk with other transcription factors are 
allowed. Thus, we can speculate that, in zebrafish grs357-/- mutants, 
similarly to the corresponding human GR R477H mutant that 
maintains full capacity to repress TNFα-induced NF-κB activity, some 
genomic functions not mediated by binding to GREs are still present 
(Ruiz et al., 2013).     
Our results suggest that the GC signaling pathway exerts a basic 
integrative function by targeting genes that confer priority for 
resource access and consumption. Specifically, during embryonic and 
larval development, EGFP was expressed in organs and body parts 
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undergoing fast proliferation and differentiation, like head, tail, fins 
and primitive intestine with its hepatic and pancreatic offshoots.  
In the ia20 line fluorescence was also precociously detected in fast 
developing sensory organs, like the eyes, the olfactory bulbs and 
tracts, and in other structures such as otic vesicles, pituitary and 
epiphysis. Energy allocation to these structures is justified by the 
immediate need of the larva to scan and process environmental cues 
into adaptive responses.  
Furthermore, the role of activated GR in timing resource assignment 
is supported by the responses in terms of egfp transcript and protein 
disclosed by WMISH and fluorescence analysis in larvae exposed to 
standard photoperiodic regime as well as fkbp5 expression. The trend 
of EGFP expression and its prevalent gastro-intestinal localization are 
interpretable as a functional predisposition for food seizing and 
digestion after nighttime fasting. GC signaling appears to harmonize 
the metabolic pre-activation of those organs that are expected to be 
soon functionally active, possibly by entraining local clocks. This 
hypothesis may be supported by the well-known surge in HPA axis 
activity before awakening in humans and other mammals (Chung et 
al., 2011). Of interest is the report that circadian cell proliferation 
rhythms were severely compromised by shutting down GC signaling 
in mutant zebrafish larvae with corticotrope deficiency whereas 
circadian rhythm effects were rescued by DEX treatment (Dickmeis et 
al., 2007). Dickmeis and colleagues (2007) hypothesized that GCs 
fluctuations during day time might lead to an involvement of 
peripheral circadian clock in the regulation of cell proliferation. 
Moreover, in mammals, regulation of a large proportion of the 
hepatic circadian transcriptome by GC signaling has been recently 
reported (Reddy et al., 2007). 
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8. FINAL CONCLUSIONS 
In this thesis we described the setting and validation of a new 
transgenic GCs responsive line. Not only we detected transgene 
activation in well-known GC targets such as liver, bone, muscle or 
brain as we expected, but we also found positivity in other structures, 
like olfactory complex, otic vesicles or putative KA’’ cells, which was 
actually a novelty. We showed that the ia20 line responds to 
glucocorticoids in a very selective way, at least during early 
development. Moreover, preliminary experiments on grs357 mutants 
seem to confirm the specificity of this responsiveness in some tissues 
during adulthood.  
GCs response was dose-dependent and exogenous GCs 
responsiveness was maintained until adult life. These results illustrate 
the potential of this transgenic line for deepening knowledge on GCs 
functions during both development and adult life. Due to its 
sensitivity to slight GCs concentration fluctuation, the ia20 line can be 
assumed to be suitable for pharmacology and toxicology studies, in 
order to detect the GREs-mediated Gr involvement in the response to 
drugs or toxic compounds even at very low concentrations.  
Further experiments will be necessary to characterize the cross-
reactivity of the transgenic line among different steroid receptors 
during adult life. In particular, we will perform several steroid 
(progesterone, androgens and mineralocorticoids) treatments on 
adult ia20 and ia20/grs357-/- fish, in order to understand if and in 
which tissues the related receptors can regulate gene transcription by 
binding to GREs. As well as grs357, the transgenic line could be, in the 
future, put under any mutant background, acting as a potent in vivo 
tool to unravel Gr involvement in a huge number of biological 
processes. 
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